id	sid	tid	token	lemma	pos
ajcp-829	1	1	pa	pa	PROPN
ajcp-829	1	2	ge	ge	PROPN
ajcp-829	1	3	1	1	NUM
ajcp-829	1	4	pa	pa	PROPN
ajcp-829	1	5	ge	ge	PROPN
ajcp-829	1	6	5	5	NUM
ajcp-829	1	7	american	american	PROPN
ajcp-829	1	8	journal	journal	PROPN
ajcp-829	1	9	of	of	ADP
ajcp-829	1	10	chemistry	chemistry	NOUN
ajcp-829	1	11	and	and	CCONJ
ajcp-829	1	12	pharmacy	pharmacy	NOUN
ajcp-829	1	13	(	(	PUNCT
ajcp-829	1	14	ajcp	ajcp	NOUN
ajcp-829	1	15	)	)	PUNCT
ajcp-829	1	16	oral	oral	ADJ
ajcp-829	1	17	acyclovir	acyclovir	PROPN
ajcp-829	1	18	induced	induce	VERB
ajcp-829	1	19	acute	acute	ADJ
ajcp-829	1	20	kidney	kidney	PROPN
ajcp-829	1	21	injury	injury	NOUN
ajcp-829	1	22	yasser	yasser	PROPN
ajcp-829	1	23	sadawey1	sadawey1	PROPN
ajcp-829	1	24	*	*	PUNCT
ajcp-829	1	25	,	,	PUNCT
ajcp-829	1	26	yasameen	yasameen	INTJ
ajcp-829	1	27	abdulhameed1	abdulhameed1	PROPN
ajcp-829	1	28	volume	volume	NOUN
ajcp-829	1	29	1	1	NUM
ajcp-829	1	30	issue	issue	NOUN
ajcp-829	1	31	2	2	NUM
ajcp-829	1	32	,	,	PUNCT
ajcp-829	1	33	year	year	NOUN
ajcp-829	1	34	2022	2022	NUM
ajcp-829	1	35	issn	issn	X
ajcp-829	1	36	:	:	PUNCT
ajcp-829	1	37	2834	2834	NUM
ajcp-829	1	38	-	-	SYM
ajcp-829	1	39	0116	0116	NUM
ajcp-829	1	40	(	(	PUNCT
ajcp-829	1	41	online	online	ADJ
ajcp-829	1	42	)	)	PUNCT
ajcp-829	1	43	doi	doi	NOUN
ajcp-829	1	44	:	:	PUNCT
ajcp-829	1	45	https://doi.org/10.54536/ajcp.v1i2.829	https://doi.org/10.54536/ajcp.v1i2.829	PROPN
ajcp-829	1	46	https://journals.e-palli.com/home/index.php/ajcp	https://journals.e-palli.com/home/index.php/ajcp	PROPN
ajcp-829	1	47	article	article	NOUN
ajcp-829	1	48	information	information	NOUN
ajcp-829	1	49	abstract	abstract	ADV
ajcp-829	1	50	received	receive	VERB
ajcp-829	1	51	:	:	PUNCT
ajcp-829	1	52	october	october	PROPN
ajcp-829	1	53	18	18	NUM
ajcp-829	1	54	,	,	PUNCT
ajcp-829	1	55	2022	2022	NUM
ajcp-829	1	56	accepted	accept	VERB
ajcp-829	1	57	:	:	PUNCT
ajcp-829	1	58	october	october	PROPN
ajcp-829	1	59	29	29	NUM
ajcp-829	1	60	,	,	PUNCT
ajcp-829	1	61	2022	2022	NUM
ajcp-829	1	62	published	publish	VERB
ajcp-829	1	63	:	:	PUNCT
ajcp-829	1	64	november	november	PROPN
ajcp-829	1	65	01	01	NUM
ajcp-829	1	66	,	,	PUNCT
ajcp-829	1	67	2022	2022	NUM
ajcp-829	1	68	acyclovir	acyclovir	PROPN
ajcp-829	1	69	is	be	AUX
ajcp-829	1	70	an	an	DET
ajcp-829	1	71	antiviral	antiviral	ADJ
ajcp-829	1	72	medication	medication	NOUN
ajcp-829	1	73	often	often	ADV
ajcp-829	1	74	used	use	VERB
ajcp-829	1	75	to	to	PART
ajcp-829	1	76	treat	treat	VERB
ajcp-829	1	77	outbreaks	outbreak	NOUN
ajcp-829	1	78	of	of	ADP
ajcp-829	1	79	herpes	herpe	NOUN
ajcp-829	1	80	in	in	ADP
ajcp-829	1	81	children	child	NOUN
ajcp-829	1	82	.	.	PUNCT
ajcp-829	2	1	acyclovir	acyclovir	PROPN
ajcp-829	2	2	has	have	VERB
ajcp-829	2	3	an	an	DET
ajcp-829	2	4	exceptional	exceptional	ADJ
ajcp-829	2	5	safety	safety	NOUN
ajcp-829	2	6	profile	profile	NOUN
ajcp-829	2	7	;	;	PUNCT
ajcp-829	2	8	there	there	PRON
ajcp-829	2	9	is	be	VERB
ajcp-829	2	10	a	a	DET
ajcp-829	2	11	possibility	possibility	NOUN
ajcp-829	2	12	that	that	SCONJ
ajcp-829	2	13	it	it	PRON
ajcp-829	2	14	might	might	AUX
ajcp-829	2	15	induce	induce	VERB
ajcp-829	2	16	severe	severe	ADJ
ajcp-829	2	17	nephrotoxicity	nephrotoxicity	NOUN
ajcp-829	2	18	in	in	ADP
ajcp-829	2	19	rare	rare	ADJ
ajcp-829	2	20	cases	case	NOUN
ajcp-829	2	21	.	.	PUNCT
ajcp-829	3	1	in	in	ADP
ajcp-829	3	2	this	this	DET
ajcp-829	3	3	report	report	NOUN
ajcp-829	3	4	,	,	PUNCT
ajcp-829	3	5	we	we	PRON
ajcp-829	3	6	present	present	VERB
ajcp-829	3	7	the	the	DET
ajcp-829	3	8	case	case	NOUN
ajcp-829	3	9	of	of	ADP
ajcp-829	3	10	a	a	DET
ajcp-829	3	11	17	17	NUM
ajcp-829	3	12	-	-	PUNCT
ajcp-829	3	13	year	year	NOUN
ajcp-829	3	14	-	-	PUNCT
ajcp-829	3	15	old	old	ADJ
ajcp-829	3	16	girl	girl	NOUN
ajcp-829	3	17	with	with	ADP
ajcp-829	3	18	acute	acute	ADJ
ajcp-829	3	19	renal	renal	ADJ
ajcp-829	3	20	injury	injury	NOUN
ajcp-829	3	21	as	as	ADP
ajcp-829	3	22	a	a	DET
ajcp-829	3	23	side	side	ADJ
ajcp-829	3	24	effect	effect	NOUN
ajcp-829	3	25	of	of	ADP
ajcp-829	3	26	using	use	VERB
ajcp-829	3	27	acyclovir	acyclovir	PROPN
ajcp-829	3	28	.	.	PUNCT
ajcp-829	4	1	the	the	DET
ajcp-829	4	2	patient	patient	NOUN
ajcp-829	4	3	was	be	AUX
ajcp-829	4	4	admitted	admit	VERB
ajcp-829	4	5	for	for	ADP
ajcp-829	4	6	three	three	NUM
ajcp-829	4	7	days	day	NOUN
ajcp-829	4	8	due	due	ADP
ajcp-829	4	9	to	to	ADP
ajcp-829	4	10	drug	drug	NOUN
ajcp-829	4	11	-	-	PUNCT
ajcp-829	4	12	induced	induce	VERB
ajcp-829	4	13	aki	aki	NOUN
ajcp-829	4	14	,	,	PUNCT
ajcp-829	4	15	which	which	PRON
ajcp-829	4	16	was	be	AUX
ajcp-829	4	17	reversed	reverse	VERB
ajcp-829	4	18	by	by	ADP
ajcp-829	4	19	discontinuing	discontinue	VERB
ajcp-829	4	20	the	the	DET
ajcp-829	4	21	afflicted	afflict	VERB
ajcp-829	4	22	medicine	medicine	NOUN
ajcp-829	4	23	(	(	PUNCT
ajcp-829	4	24	acyclovir	acyclovir	PROPN
ajcp-829	4	25	)	)	PUNCT
ajcp-829	4	26	,	,	PUNCT
ajcp-829	4	27	initiating	initiate	VERB
ajcp-829	4	28	appropriate	appropriate	ADJ
ajcp-829	4	29	hydration	hydration	NOUN
ajcp-829	4	30	with	with	ADP
ajcp-829	4	31	intravenous	intravenous	ADJ
ajcp-829	4	32	normal	normal	ADJ
ajcp-829	4	33	saline	saline	NOUN
ajcp-829	4	34	0.9	0.9	NUM
ajcp-829	4	35	%	%	NOUN
ajcp-829	4	36	,	,	PUNCT
ajcp-829	4	37	and	and	CCONJ
ajcp-829	4	38	refraining	refrain	VERB
ajcp-829	4	39	from	from	ADP
ajcp-829	4	40	any	any	DET
ajcp-829	4	41	nephrotoxic	nephrotoxic	ADJ
ajcp-829	4	42	medications	medication	NOUN
ajcp-829	4	43	.	.	PUNCT
ajcp-829	5	1	following	follow	VERB
ajcp-829	5	2	up	up	ADP
ajcp-829	5	3	a	a	DET
ajcp-829	5	4	week	week	NOUN
ajcp-829	5	5	later	later	ADV
ajcp-829	5	6	,	,	PUNCT
ajcp-829	5	7	the	the	DET
ajcp-829	5	8	patient	patient	NOUN
ajcp-829	5	9	was	be	AUX
ajcp-829	5	10	asymptomatic	asymptomatic	ADJ
ajcp-829	5	11	and	and	CCONJ
ajcp-829	5	12	had	have	VERB
ajcp-829	5	13	normal	normal	ADJ
ajcp-829	5	14	kidney	kidney	NOUN
ajcp-829	5	15	function	function	NOUN
ajcp-829	5	16	.	.	PUNCT
ajcp-829	6	1	therefore	therefore	ADV
ajcp-829	6	2	,	,	PUNCT
ajcp-829	6	3	it	it	PRON
ajcp-829	6	4	is	be	AUX
ajcp-829	6	5	critical	critical	ADJ
ajcp-829	6	6	to	to	PART
ajcp-829	6	7	use	use	VERB
ajcp-829	6	8	acyclovir	acyclovir	PROPN
ajcp-829	6	9	correctly	correctly	ADV
ajcp-829	6	10	to	to	PART
ajcp-829	6	11	avoid	avoid	VERB
ajcp-829	6	12	possibly	possibly	ADV
ajcp-829	6	13	fatal	fatal	ADJ
ajcp-829	6	14	consequences	consequence	NOUN
ajcp-829	6	15	.	.	PUNCT
ajcp-829	7	1	keywords	keyword	NOUN
ajcp-829	7	2	oral	oral	ADJ
ajcp-829	7	3	acyclovir	acyclovir	PROPN
ajcp-829	7	4	,	,	PUNCT
ajcp-829	7	5	acute	acute	ADJ
ajcp-829	7	6	kidney	kidney	NOUN
ajcp-829	7	7	injury	injury	PROPN
ajcp-829	7	8	,	,	PUNCT
ajcp-829	7	9	acyclovir	acyclovir	PROPN
ajcp-829	7	10	nephrotoxicity	nephrotoxicity	PROPN
ajcp-829	7	11	,	,	PUNCT
ajcp-829	7	12	medicine	medicine	NOUN
ajcp-829	7	13	1	1	NUM
ajcp-829	7	14	department	department	NOUN
ajcp-829	7	15	of	of	ADP
ajcp-829	7	16	medicine	medicine	NOUN
ajcp-829	7	17	,	,	PUNCT
ajcp-829	7	18	mediclinic	mediclinic	ADJ
ajcp-829	7	19	me	i	PRON
ajcp-829	7	20	,	,	PUNCT
ajcp-829	7	21	al	al	PROPN
ajcp-829	7	22	jowhara	jowhara	PROPN
ajcp-829	7	23	hospital	hospital	PROPN
ajcp-829	7	24	,	,	PUNCT
ajcp-829	7	25	al	al	PROPN
ajcp-829	7	26	ain	ain	PROPN
ajcp-829	7	27	,	,	PUNCT
ajcp-829	7	28	uae	uae	PROPN
ajcp-829	7	29	*	*	PUNCT
ajcp-829	7	30	corresponding	correspond	VERB
ajcp-829	7	31	author	author	NOUN
ajcp-829	7	32	’s	’s	PART
ajcp-829	7	33	e	e	NOUN
ajcp-829	7	34	-	-	NOUN
ajcp-829	7	35	mail	mail	NOUN
ajcp-829	7	36	:	:	PUNCT
ajcp-829	7	37	yassersadawey12@outlook.com	yassersadawey12@outlook.com	X
ajcp-829	7	38	introduction	introduction	NOUN
ajcp-829	7	39	acyclovir	acyclovir	PROPN
ajcp-829	7	40	is	be	AUX
ajcp-829	7	41	now	now	ADV
ajcp-829	7	42	the	the	DET
ajcp-829	7	43	most	most	ADV
ajcp-829	7	44	effective	effective	ADJ
ajcp-829	7	45	treatment	treatment	NOUN
ajcp-829	7	46	for	for	ADP
ajcp-829	7	47	several	several	ADJ
ajcp-829	7	48	herpes	herpe	NOUN
ajcp-829	7	49	viruses	virus	NOUN
ajcp-829	7	50	,	,	PUNCT
ajcp-829	7	51	such	such	ADJ
ajcp-829	7	52	as	as	ADP
ajcp-829	7	53	herpes	herpe	NOUN
ajcp-829	7	54	encephalitis	encephalitis	NOUN
ajcp-829	7	55	(	(	PUNCT
ajcp-829	7	56	balfour	balfour	PROPN
ajcp-829	7	57	h.	h.	PROPN
ajcp-829	7	58	h.	h.	PROPN
ajcp-829	7	59	,	,	PUNCT
ajcp-829	7	60	1984	1984	NUM
ajcp-829	7	61	;	;	PUNCT
ajcp-829	7	62	yy	yy	PROPN
ajcp-829	7	63	.	.	PROPN
ajcp-829	7	64	,	,	PUNCT
ajcp-829	7	65	1984	1984	NUM
ajcp-829	7	66	)	)	PUNCT
ajcp-829	7	67	,	,	PUNCT
ajcp-829	7	68	varicella	varicella	NOUN
ajcp-829	7	69	zoster	zoster	PROPN
ajcp-829	7	70	virus	virus	PROPN
ajcp-829	7	71	(	(	PUNCT
ajcp-829	7	72	vzv	vzv	PROPN
ajcp-829	7	73	)	)	PUNCT
ajcp-829	7	74	,	,	PUNCT
ajcp-829	7	75	or	or	CCONJ
ajcp-829	7	76	herpes	herpe	NOUN
ajcp-829	7	77	simplex	simplex	NOUN
ajcp-829	7	78	virus	virus	NOUN
ajcp-829	7	79	(	(	PUNCT
ajcp-829	7	80	hsv	hsv	PROPN
ajcp-829	7	81	)	)	PUNCT
ajcp-829	7	82	infections	infection	NOUN
ajcp-829	7	83	in	in	ADP
ajcp-829	7	84	children	child	NOUN
ajcp-829	7	85	with	with	ADP
ajcp-829	7	86	compromised	compromise	VERB
ajcp-829	7	87	immune	immune	ADJ
ajcp-829	7	88	systems	system	NOUN
ajcp-829	7	89	.	.	PUNCT
ajcp-829	8	1	in	in	ADP
ajcp-829	8	2	addition	addition	NOUN
ajcp-829	8	3	,	,	PUNCT
ajcp-829	8	4	high	high	ADV
ajcp-829	8	5	-	-	PUNCT
ajcp-829	8	6	dose	dose	NOUN
ajcp-829	8	7	intravenous	intravenous	ADJ
ajcp-829	8	8	acyclovir	acyclovir	PROPN
ajcp-829	8	9	to	to	PART
ajcp-829	8	10	combat	combat	VERB
ajcp-829	8	11	viral	viral	ADJ
ajcp-829	8	12	infections	infection	NOUN
ajcp-829	8	13	may	may	AUX
ajcp-829	8	14	be	be	AUX
ajcp-829	8	15	beneficial	beneficial	ADJ
ajcp-829	8	16	(	(	PUNCT
ajcp-829	8	17	yy	yy	PROPN
ajcp-829	8	18	.	.	PROPN
ajcp-829	8	19	,	,	PUNCT
ajcp-829	8	20	1984	1984	NUM
ajcp-829	8	21	)	)	PUNCT
ajcp-829	8	22	.	.	PUNCT
ajcp-829	9	1	the	the	DET
ajcp-829	9	2	adverse	adverse	ADJ
ajcp-829	9	3	effects	effect	NOUN
ajcp-829	9	4	of	of	ADP
ajcp-829	9	5	acyclovir	acyclovir	PROPN
ajcp-829	9	6	are	be	AUX
ajcp-829	9	7	well	well	ADV
ajcp-829	9	8	-	-	PUNCT
ajcp-829	9	9	known	know	VERB
ajcp-829	9	10	;	;	PUNCT
ajcp-829	9	11	nonetheless	nonetheless	ADV
ajcp-829	9	12	,	,	PUNCT
ajcp-829	9	13	most	most	ADJ
ajcp-829	9	14	people	people	NOUN
ajcp-829	9	15	do	do	AUX
ajcp-829	9	16	not	not	PART
ajcp-829	9	17	consider	consider	VERB
ajcp-829	9	18	it	it	PRON
ajcp-829	9	19	.	.	PUNCT
ajcp-829	10	1	the	the	DET
ajcp-829	10	2	most	most	ADV
ajcp-829	10	3	prevalent	prevalent	ADJ
ajcp-829	10	4	underlying	underlying	ADJ
ajcp-829	10	5	mechanism	mechanism	NOUN
ajcp-829	10	6	that	that	PRON
ajcp-829	10	7	acyclovir	acyclovir	PROPN
ajcp-829	10	8	may	may	AUX
ajcp-829	10	9	generate	generate	VERB
ajcp-829	10	10	is	be	AUX
ajcp-829	10	11	crystal	crystal	NOUN
ajcp-829	10	12	nephropathy	nephropathy	NOUN
ajcp-829	10	13	,	,	PUNCT
ajcp-829	10	14	which	which	PRON
ajcp-829	10	15	is	be	AUX
ajcp-829	10	16	reported	report	VERB
ajcp-829	10	17	to	to	PART
ajcp-829	10	18	have	have	VERB
ajcp-829	10	19	the	the	DET
ajcp-829	10	20	adverse	adverse	ADJ
ajcp-829	10	21	side	side	NOUN
ajcp-829	10	22	effect	effect	NOUN
ajcp-829	10	23	of	of	ADP
ajcp-829	10	24	inducing	induce	VERB
ajcp-829	10	25	acute	acute	ADJ
ajcp-829	10	26	renal	renal	ADJ
ajcp-829	10	27	injury	injury	NOUN
ajcp-829	10	28	(	(	PUNCT
ajcp-829	10	29	aki	aki	NOUN
ajcp-829	10	30	)	)	PUNCT
ajcp-829	10	31	.	.	PUNCT
ajcp-829	11	1	it	it	PRON
ajcp-829	11	2	is	be	AUX
ajcp-829	11	3	hypothesized	hypothesize	VERB
ajcp-829	11	4	that	that	SCONJ
ajcp-829	11	5	the	the	DET
ajcp-829	11	6	mechanism	mechanism	NOUN
ajcp-829	11	7	that	that	PRON
ajcp-829	11	8	causes	cause	VERB
ajcp-829	11	9	the	the	DET
ajcp-829	11	10	damage	damage	NOUN
ajcp-829	11	11	is	be	AUX
ajcp-829	11	12	the	the	DET
ajcp-829	11	13	precipitation	precipitation	NOUN
ajcp-829	11	14	and	and	CCONJ
ajcp-829	11	15	crystallisation	crystallisation	NOUN
ajcp-829	11	16	of	of	ADP
ajcp-829	11	17	the	the	DET
ajcp-829	11	18	medicine	medicine	NOUN
ajcp-829	11	19	inside	inside	ADP
ajcp-829	11	20	the	the	DET
ajcp-829	11	21	renal	renal	ADJ
ajcp-829	11	22	tubules	tubule	NOUN
ajcp-829	11	23	,	,	PUNCT
ajcp-829	11	24	which	which	PRON
ajcp-829	11	25	results	result	VERB
ajcp-829	11	26	in	in	ADP
ajcp-829	11	27	obstruction	obstruction	NOUN
ajcp-829	11	28	and	and	CCONJ
ajcp-829	11	29	perhaps	perhaps	ADV
ajcp-829	11	30	cellular	cellular	ADJ
ajcp-829	11	31	necrosis	necrosis	NOUN
ajcp-829	11	32	(	(	PUNCT
ajcp-829	11	33	izzedine	izzedine	ADJ
ajcp-829	11	34	,	,	PUNCT
ajcp-829	11	35	2005	2005	NUM
ajcp-829	11	36	;	;	PUNCT
ajcp-829	11	37	mason	mason	PROPN
ajcp-829	11	38	,	,	PUNCT
ajcp-829	11	39	2008	2008	NUM
ajcp-829	11	40	)	)	PUNCT
ajcp-829	11	41	.	.	PUNCT
ajcp-829	12	1	patients	patient	NOUN
ajcp-829	12	2	with	with	ADP
ajcp-829	12	3	acyclovir	acyclovir	PROPN
ajcp-829	12	4	-	-	PUNCT
ajcp-829	12	5	induced	induce	VERB
ajcp-829	12	6	acute	acute	NOUN
ajcp-829	12	7	kidney	kidney	NOUN
ajcp-829	12	8	injury	injury	NOUN
ajcp-829	12	9	have	have	VERB
ajcp-829	12	10	a	a	DET
ajcp-829	12	11	fast	fast	ADJ
ajcp-829	12	12	reduction	reduction	NOUN
ajcp-829	12	13	in	in	ADP
ajcp-829	12	14	their	their	PRON
ajcp-829	12	15	renal	renal	ADJ
ajcp-829	12	16	function	function	NOUN
ajcp-829	12	17	and	and	CCONJ
ajcp-829	12	18	an	an	DET
ajcp-829	12	19	increase	increase	NOUN
ajcp-829	12	20	in	in	ADP
ajcp-829	12	21	their	their	PRON
ajcp-829	12	22	blood	blood	NOUN
ajcp-829	12	23	creatinine	creatinine	NOUN
ajcp-829	12	24	level	level	NOUN
ajcp-829	12	25	.	.	PUNCT
ajcp-829	13	1	this	this	PRON
ajcp-829	13	2	usually	usually	ADV
ajcp-829	13	3	occurs	occur	VERB
ajcp-829	13	4	between	between	ADP
ajcp-829	13	5	12	12	NUM
ajcp-829	13	6	and	and	CCONJ
ajcp-829	13	7	48	48	NUM
ajcp-829	13	8	hours	hour	NOUN
ajcp-829	13	9	after	after	ADP
ajcp-829	13	10	administering	administer	VERB
ajcp-829	13	11	the	the	DET
ajcp-829	13	12	medicine	medicine	NOUN
ajcp-829	13	13	(	(	PUNCT
ajcp-829	13	14	yildiz	yildiz	PROPN
ajcp-829	13	15	c	c	PROPN
ajcp-829	13	16	,	,	PUNCT
ajcp-829	13	17	2013	2013	NUM
ajcp-829	13	18	;	;	PUNCT
ajcp-829	13	19	zhang	zhang	PROPN
ajcp-829	13	20	y	y	PROPN
ajcp-829	13	21	,	,	PUNCT
ajcp-829	13	22	2016	2016	NUM
ajcp-829	13	23	)	)	PUNCT
ajcp-829	13	24	.	.	PUNCT
ajcp-829	14	1	appropriate	appropriate	ADJ
ajcp-829	14	2	diagnosis	diagnosis	NOUN
ajcp-829	14	3	and	and	CCONJ
ajcp-829	14	4	management	management	NOUN
ajcp-829	14	5	of	of	ADP
ajcp-829	14	6	aki	aki	NOUN
ajcp-829	14	7	caused	cause	VERB
ajcp-829	14	8	by	by	ADP
ajcp-829	14	9	acyclovir	acyclovir	PROPN
ajcp-829	14	10	are	be	AUX
ajcp-829	14	11	necessary	necessary	ADJ
ajcp-829	14	12	for	for	ADP
ajcp-829	14	13	an	an	DET
ajcp-829	14	14	effective	effective	ADJ
ajcp-829	14	15	prognosis(zhang	prognosis(zhang	PROPN
ajcp-829	14	16	y	y	PROPN
ajcp-829	14	17	,	,	PUNCT
ajcp-829	14	18	2016	2016	NUM
ajcp-829	14	19	)	)	PUNCT
ajcp-829	14	20	.	.	PUNCT
ajcp-829	15	1	in	in	ADP
ajcp-829	15	2	this	this	DET
ajcp-829	15	3	report	report	NOUN
ajcp-829	15	4	,	,	PUNCT
ajcp-829	15	5	we	we	PRON
ajcp-829	15	6	present	present	VERB
ajcp-829	15	7	a	a	DET
ajcp-829	15	8	case	case	NOUN
ajcp-829	15	9	of	of	ADP
ajcp-829	15	10	a	a	DET
ajcp-829	15	11	17	17	NUM
ajcp-829	15	12	-	-	PUNCT
ajcp-829	15	13	year	year	NOUN
ajcp-829	15	14	-	-	PUNCT
ajcp-829	15	15	old	old	ADJ
ajcp-829	15	16	girl	girl	NOUN
ajcp-829	15	17	who	who	PRON
ajcp-829	15	18	developed	develop	VERB
ajcp-829	15	19	an	an	DET
ajcp-829	15	20	acute	acute	ADJ
ajcp-829	15	21	kidney	kidney	NOUN
ajcp-829	15	22	injury	injury	NOUN
ajcp-829	15	23	as	as	ADP
ajcp-829	15	24	a	a	DET
ajcp-829	15	25	side	side	ADJ
ajcp-829	15	26	effect	effect	NOUN
ajcp-829	15	27	of	of	ADP
ajcp-829	15	28	acyclovir	acyclovir	PROPN
ajcp-829	15	29	in	in	ADP
ajcp-829	15	30	the	the	DET
ajcp-829	15	31	management	management	NOUN
ajcp-829	15	32	of	of	ADP
ajcp-829	15	33	herpes	herpe	NOUN
ajcp-829	15	34	zoster	zoster	ADJ
ajcp-829	15	35	infection	infection	NOUN
ajcp-829	15	36	.	.	PUNCT
ajcp-829	16	1	methodology	methodology	NOUN
ajcp-829	16	2	case	case	NOUN
ajcp-829	16	3	presentation	presentation	NOUN
ajcp-829	16	4	seventeen	seventeen	NUM
ajcp-829	16	5	years	year	NOUN
ajcp-829	16	6	old	old	ADJ
ajcp-829	16	7	female	female	NOUN
ajcp-829	16	8	with	with	ADP
ajcp-829	16	9	known	know	VERB
ajcp-829	16	10	epilepsy	epilepsy	NOUN
ajcp-829	16	11	was	be	AUX
ajcp-829	16	12	admitted	admit	VERB
ajcp-829	16	13	to	to	ADP
ajcp-829	16	14	our	our	PRON
ajcp-829	16	15	hospital	hospital	NOUN
ajcp-829	16	16	.	.	PUNCT
ajcp-829	17	1	she	she	PRON
ajcp-829	17	2	was	be	AUX
ajcp-829	17	3	diagnosed	diagnose	VERB
ajcp-829	17	4	five	five	NUM
ajcp-829	17	5	years	year	NOUN
ajcp-829	17	6	ago	ago	ADV
ajcp-829	17	7	with	with	ADP
ajcp-829	17	8	epilepsy	epilepsy	NOUN
ajcp-829	17	9	and	and	CCONJ
ajcp-829	17	10	started	start	VERB
ajcp-829	17	11	on	on	ADP
ajcp-829	17	12	treatment	treatment	NOUN
ajcp-829	17	13	for	for	ADP
ajcp-829	17	14	a	a	DET
ajcp-829	17	15	few	few	ADJ
ajcp-829	17	16	weeks	week	NOUN
ajcp-829	17	17	with	with	ADP
ajcp-829	17	18	poor	poor	ADJ
ajcp-829	17	19	compliance	compliance	NOUN
ajcp-829	17	20	due	due	ADP
ajcp-829	17	21	to	to	ADP
ajcp-829	17	22	medication	medication	NOUN
ajcp-829	17	23	side	side	NOUN
ajcp-829	17	24	effects	effect	NOUN
ajcp-829	17	25	.	.	PUNCT
ajcp-829	18	1	she	she	PRON
ajcp-829	18	2	has	have	VERB
ajcp-829	18	3	a	a	DET
ajcp-829	18	4	five	five	NUM
ajcp-829	18	5	-	-	PUNCT
ajcp-829	18	6	day	day	NOUN
ajcp-829	18	7	history	history	NOUN
ajcp-829	18	8	of	of	ADP
ajcp-829	18	9	skin	skin	NOUN
ajcp-829	18	10	rash	rash	NOUN
ajcp-829	18	11	affecting	affect	VERB
ajcp-829	18	12	her	her	PRON
ajcp-829	18	13	upper	upper	ADJ
ajcp-829	18	14	back	back	NOUN
ajcp-829	18	15	and	and	CCONJ
ajcp-829	18	16	right	right	ADJ
ajcp-829	18	17	shoulder	shoulder	NOUN
ajcp-829	18	18	(	(	PUNCT
ajcp-829	18	19	itchy	itchy	ADJ
ajcp-829	18	20	,	,	PUNCT
ajcp-829	18	21	vesicular	vesicular	ADJ
ajcp-829	18	22	,	,	PUNCT
ajcp-829	18	23	painful	painful	ADJ
ajcp-829	18	24	,	,	PUNCT
ajcp-829	18	25	and	and	CCONJ
ajcp-829	18	26	affecting	affect	VERB
ajcp-829	18	27	a	a	DET
ajcp-829	18	28	dermatomal	dermatomal	ADJ
ajcp-829	18	29	distribution	distribution	NOUN
ajcp-829	18	30	of	of	ADP
ajcp-829	18	31	cervical	cervical	ADJ
ajcp-829	18	32	4,5	4,5	NUM
ajcp-829	18	33	and	and	CCONJ
ajcp-829	18	34	6	6	NUM
ajcp-829	18	35	)	)	PUNCT
ajcp-829	18	36	associated	associate	VERB
ajcp-829	18	37	with	with	ADP
ajcp-829	18	38	nausea	nausea	NOUN
ajcp-829	18	39	and	and	CCONJ
ajcp-829	18	40	vomiting	vomit	VERB
ajcp-829	18	41	at	at	ADP
ajcp-829	18	42	the	the	DET
ajcp-829	18	43	time	time	NOUN
ajcp-829	18	44	of	of	ADP
ajcp-829	18	45	admittance	admittance	NOUN
ajcp-829	18	46	in	in	ADP
ajcp-829	18	47	another	another	DET
ajcp-829	18	48	facility	facility	NOUN
ajcp-829	18	49	.	.	PUNCT
ajcp-829	19	1	during	during	ADP
ajcp-829	19	2	that	that	DET
ajcp-829	19	3	period	period	NOUN
ajcp-829	19	4	,	,	PUNCT
ajcp-829	19	5	she	she	PRON
ajcp-829	19	6	was	be	AUX
ajcp-829	19	7	started	start	VERB
ajcp-829	19	8	on	on	ADP
ajcp-829	19	9	acyclovir	acyclovir	PROPN
ajcp-829	19	10	800	800	NUM
ajcp-829	19	11	mg	mg	ADP
ajcp-829	19	12	orally	orally	ADV
ajcp-829	19	13	three	three	NUM
ajcp-829	19	14	times	time	NOUN
ajcp-829	19	15	daily	daily	ADV
ajcp-829	19	16	for	for	ADP
ajcp-829	19	17	the	the	DET
ajcp-829	19	18	diagnosis	diagnosis	NOUN
ajcp-829	19	19	of	of	ADP
ajcp-829	19	20	herpes	herpe	NOUN
ajcp-829	19	21	zoster	zoster	ADJ
ajcp-829	19	22	infection	infection	NOUN
ajcp-829	19	23	,	,	PUNCT
ajcp-829	19	24	diclofenac	diclofenac	NOUN
ajcp-829	19	25	sodium	sodium	NOUN
ajcp-829	19	26	50	50	NUM
ajcp-829	19	27	mg	mg	NOUN
ajcp-829	19	28	twice	twice	ADV
ajcp-829	19	29	and	and	CCONJ
ajcp-829	19	30	levetiracetam	levetiracetam	NOUN
ajcp-829	19	31	500	500	NUM
ajcp-829	19	32	mg	mg	NOUN
ajcp-829	19	33	orally	orally	ADV
ajcp-829	19	34	every	every	DET
ajcp-829	19	35	12	12	NUM
ajcp-829	19	36	hours	hour	NOUN
ajcp-829	19	37	.	.	PUNCT
ajcp-829	20	1	unfortunately	unfortunately	ADV
ajcp-829	20	2	,	,	PUNCT
ajcp-829	20	3	she	she	PRON
ajcp-829	20	4	was	be	AUX
ajcp-829	20	5	discharged	discharge	VERB
ajcp-829	20	6	one	one	NUM
ajcp-829	20	7	day	day	NOUN
ajcp-829	20	8	before	before	ADP
ajcp-829	20	9	her	her	PRON
ajcp-829	20	10	current	current	ADJ
ajcp-829	20	11	presentation	presentation	NOUN
ajcp-829	20	12	to	to	ADP
ajcp-829	20	13	our	our	PRON
ajcp-829	20	14	hospital	hospital	NOUN
ajcp-829	20	15	.	.	PUNCT
ajcp-829	21	1	she	she	PRON
ajcp-829	21	2	also	also	ADV
ajcp-829	21	3	gave	give	VERB
ajcp-829	21	4	a	a	DET
ajcp-829	21	5	history	history	NOUN
ajcp-829	21	6	of	of	ADP
ajcp-829	21	7	reduced	reduce	VERB
ajcp-829	21	8	urine	urine	NOUN
ajcp-829	21	9	output	output	NOUN
ajcp-829	21	10	.	.	PUNCT
ajcp-829	22	1	upon	upon	SCONJ
ajcp-829	22	2	arrival	arrival	NOUN
ajcp-829	22	3	,	,	PUNCT
ajcp-829	22	4	she	she	PRON
ajcp-829	22	5	was	be	AUX
ajcp-829	22	6	vitally	vitally	ADV
ajcp-829	22	7	stable	stable	ADJ
ajcp-829	22	8	and	and	CCONJ
ajcp-829	22	9	afebrile	afebrile	ADJ
ajcp-829	22	10	,	,	PUNCT
ajcp-829	22	11	weighted	weight	VERB
ajcp-829	22	12	60	60	NUM
ajcp-829	22	13	kg	kg	NOUN
ajcp-829	22	14	with	with	ADP
ajcp-829	22	15	normal	normal	ADJ
ajcp-829	22	16	capillary	capillary	ADJ
ajcp-829	22	17	refill	refill	NOUN
ajcp-829	22	18	time	time	NOUN
ajcp-829	22	19	but	but	CCONJ
ajcp-829	22	20	dry	dry	ADJ
ajcp-829	22	21	mucous	mucous	ADJ
ajcp-829	22	22	membranes	membrane	NOUN
ajcp-829	22	23	.	.	PUNCT
ajcp-829	23	1	systemic	systemic	ADJ
ajcp-829	23	2	examination	examination	NOUN
ajcp-829	23	3	,	,	PUNCT
ajcp-829	23	4	apart	apart	ADV
ajcp-829	23	5	from	from	ADP
ajcp-829	23	6	mild	mild	ADJ
ajcp-829	23	7	epigastric	epigastric	NOUN
ajcp-829	23	8	tenderness	tenderness	NOUN
ajcp-829	23	9	,	,	PUNCT
ajcp-829	23	10	was	be	AUX
ajcp-829	23	11	reported	report	VERB
ajcp-829	23	12	as	as	ADP
ajcp-829	23	13	unremarkable	unremarkable	ADJ
ajcp-829	23	14	.	.	PUNCT
ajcp-829	24	1	neurological	neurological	ADJ
ajcp-829	24	2	examination	examination	NOUN
ajcp-829	24	3	revealed	reveal	VERB
ajcp-829	24	4	unremarkable	unremarkable	ADJ
ajcp-829	24	5	results	result	NOUN
ajcp-829	24	6	,	,	PUNCT
ajcp-829	24	7	including	include	VERB
ajcp-829	24	8	motor	motor	NOUN
ajcp-829	24	9	,	,	PUNCT
ajcp-829	24	10	sensory	sensory	ADJ
ajcp-829	24	11	,	,	PUNCT
ajcp-829	24	12	cranial	cranial	ADJ
ajcp-829	24	13	nerves	nerve	NOUN
ajcp-829	24	14	,	,	PUNCT
ajcp-829	24	15	and	and	CCONJ
ajcp-829	24	16	cerebellar	cerebellar	ADJ
ajcp-829	24	17	functions	function	NOUN
ajcp-829	24	18	,	,	PUNCT
ajcp-829	24	19	and	and	CCONJ
ajcp-829	24	20	no	no	DET
ajcp-829	24	21	photophobia	photophobia	NOUN
ajcp-829	24	22	or	or	CCONJ
ajcp-829	24	23	neck	neck	NOUN
ajcp-829	24	24	stiffness	stiffness	NOUN
ajcp-829	24	25	.	.	PUNCT
ajcp-829	25	1	chest	chest	NOUN
ajcp-829	25	2	x	x	NOUN
ajcp-829	25	3	-	-	NOUN
ajcp-829	25	4	ray	ray	NOUN
ajcp-829	25	5	and	and	CCONJ
ajcp-829	25	6	ultrasound	ultrasound	NOUN
ajcp-829	25	7	abdomen	abdoman	NOUN
ajcp-829	25	8	were	be	AUX
ajcp-829	25	9	unremarkable	unremarkable	ADJ
ajcp-829	25	10	.	.	PUNCT
ajcp-829	26	1	ct	ct	NUM
ajcp-829	26	2	head	head	NOUN
ajcp-829	26	3	done	do	VERB
ajcp-829	26	4	earlier	early	ADV
ajcp-829	26	5	showed	show	VERB
ajcp-829	26	6	mucosal	mucosal	NOUN
ajcp-829	26	7	thickening	thickening	NOUN
ajcp-829	26	8	and	and	CCONJ
ajcp-829	26	9	retention	retention	NOUN
ajcp-829	26	10	cyst	cyst	NOUN
ajcp-829	26	11	of	of	ADP
ajcp-829	26	12	left	left	ADJ
ajcp-829	26	13	maxillary	maxillary	NOUN
ajcp-829	26	14	sinuses	sinus	NOUN
ajcp-829	26	15	.	.	PUNCT
ajcp-829	27	1	her	her	PRON
ajcp-829	27	2	laboratory	laboratory	NOUN
ajcp-829	27	3	results	result	NOUN
ajcp-829	27	4	showed	show	VERB
ajcp-829	27	5	creatinine	creatinine	NOUN
ajcp-829	27	6	of	of	ADP
ajcp-829	27	7	202wµ	202wµ	PROPN
ajcp-829	27	8	mol	mol	ADP
ajcp-829	27	9	/	/	SYM
ajcp-829	27	10	l	l	NOUN
ajcp-829	27	11	,	,	PUNCT
ajcp-829	27	12	normal	normal	ADJ
ajcp-829	27	13	electrolytes	electrolyte	NOUN
ajcp-829	27	14	and	and	CCONJ
ajcp-829	27	15	ph	ph	ADJ
ajcp-829	27	16	7.33	7.33	NUM
ajcp-829	27	17	,	,	PUNCT
ajcp-829	27	18	and	and	CCONJ
ajcp-829	27	19	hco3	hco3	PROPN
ajcp-829	27	20	18	18	NUM
ajcp-829	27	21	meq	meq	NUM
ajcp-829	27	22	/	/	SYM
ajcp-829	27	23	l	l	NOUN
ajcp-829	27	24	,	,	PUNCT
ajcp-829	27	25	lactate	lactate	VERB
ajcp-829	27	26	0.8	0.8	NUM
ajcp-829	27	27	mmol	mmol	NOUN
ajcp-829	27	28	/	/	SYM
ajcp-829	27	29	l.	l.	PROPN
ajcp-829	28	1	she	she	PRON
ajcp-829	28	2	was	be	AUX
ajcp-829	28	3	admitted	admit	VERB
ajcp-829	28	4	as	as	ADP
ajcp-829	28	5	having	have	VERB
ajcp-829	28	6	acute	acute	ADJ
ajcp-829	28	7	kidney	kidney	NOUN
ajcp-829	28	8	injury	injury	NOUN
ajcp-829	28	9	,	,	PUNCT
ajcp-829	28	10	probably	probably	ADV
ajcp-829	28	11	drug	drug	NOUN
ajcp-829	28	12	-	-	PUNCT
ajcp-829	28	13	induced	induce	VERB
ajcp-829	28	14	,	,	PUNCT
ajcp-829	28	15	using	use	VERB
ajcp-829	28	16	the	the	DET
ajcp-829	28	17	naranjo	naranjo	PROPN
ajcp-829	28	18	algorithm	algorithm	NOUN
ajcp-829	28	19	of	of	ADP
ajcp-829	28	20	adverse	adverse	ADJ
ajcp-829	28	21	drug	drug	NOUN
ajcp-829	28	22	reaction	reaction	NOUN
ajcp-829	28	23	.	.	PUNCT
ajcp-829	29	1	the	the	DET
ajcp-829	29	2	patient	patient	NOUN
ajcp-829	29	3	was	be	AUX
ajcp-829	29	4	admitted	admit	VERB
ajcp-829	29	5	for	for	ADP
ajcp-829	29	6	three	three	NUM
ajcp-829	29	7	days	day	NOUN
ajcp-829	29	8	as	as	ADP
ajcp-829	29	9	drug	drug	NOUN
ajcp-829	29	10	-	-	PUNCT
ajcp-829	29	11	induced	induce	VERB
ajcp-829	29	12	aki	aki	NOUN
ajcp-829	29	13	,	,	PUNCT
ajcp-829	29	14	and	and	CCONJ
ajcp-829	29	15	the	the	DET
ajcp-829	29	16	culprit	culprit	NOUN
ajcp-829	29	17	drug	drug	NOUN
ajcp-829	29	18	(	(	PUNCT
ajcp-829	29	19	acyclovir	acyclovir	PROPN
ajcp-829	29	20	)	)	PUNCT
ajcp-829	29	21	was	be	AUX
ajcp-829	29	22	stopped	stop	VERB
ajcp-829	29	23	with	with	ADP
ajcp-829	29	24	the	the	DET
ajcp-829	29	25	initiation	initiation	NOUN
ajcp-829	29	26	of	of	ADP
ajcp-829	29	27	proper	proper	ADJ
ajcp-829	29	28	hydration	hydration	NOUN
ajcp-829	29	29	with	with	ADP
ajcp-829	29	30	normal	normal	ADJ
ajcp-829	29	31	intravenous	intravenous	ADJ
ajcp-829	29	32	saline	saline	NOUN
ajcp-829	29	33	0.9	0.9	NUM
ajcp-829	29	34	%	%	NOUN
ajcp-829	29	35	and	and	CCONJ
ajcp-829	29	36	avoiding	avoid	VERB
ajcp-829	29	37	all	all	DET
ajcp-829	29	38	nephrotoxic	nephrotoxic	ADJ
ajcp-829	29	39	medications	medication	NOUN
ajcp-829	29	40	.	.	PUNCT
ajcp-829	30	1	she	she	PRON
ajcp-829	30	2	was	be	AUX
ajcp-829	30	3	started	start	VERB
ajcp-829	30	4	on	on	ADP
ajcp-829	30	5	metoclopramide	metoclopramide	NOUN
ajcp-829	30	6	10	10	NUM
ajcp-829	30	7	mg	mg	NOUN
ajcp-829	30	8	intravenous	intravenous	ADJ
ajcp-829	30	9	when	when	SCONJ
ajcp-829	30	10	needed	need	VERB
ajcp-829	30	11	,	,	PUNCT
ajcp-829	30	12	pantoprazole	pantoprazole	PROPN
ajcp-829	30	13	40	40	NUM
ajcp-829	30	14	mg	mg	NOUN
ajcp-829	30	15	intravenous	intravenous	ADJ
ajcp-829	30	16	once	once	ADV
ajcp-829	30	17	daily	daily	ADV
ajcp-829	30	18	,	,	PUNCT
ajcp-829	30	19	and	and	CCONJ
ajcp-829	30	20	paracetamol	paracetamol	NOUN
ajcp-829	30	21	1	1	NUM
ajcp-829	30	22	gm	gm	PROPN
ajcp-829	30	23	for	for	ADP
ajcp-829	30	24	pain	pain	NOUN
ajcp-829	30	25	control	control	NOUN
ajcp-829	30	26	,	,	PUNCT
ajcp-829	30	27	daily	daily	ADJ
ajcp-829	30	28	renal	renal	ADJ
ajcp-829	30	29	function	function	NOUN
ajcp-829	30	30	tests	test	NOUN
ajcp-829	30	31	showed	show	VERB
ajcp-829	30	32	improvement	improvement	NOUN
ajcp-829	30	33	of	of	ADP
ajcp-829	30	34	kidney	kidney	NOUN
ajcp-829	30	35	functions	function	NOUN
ajcp-829	30	36	,	,	PUNCT
ajcp-829	30	37	and	and	CCONJ
ajcp-829	30	38	she	she	PRON
ajcp-829	30	39	was	be	AUX
ajcp-829	30	40	tolerant	tolerant	ADJ
ajcp-829	30	41	of	of	ADP
ajcp-829	30	42	oral	oral	ADJ
ajcp-829	30	43	intake	intake	NOUN
ajcp-829	30	44	.	.	PUNCT
ajcp-829	31	1	upon	upon	SCONJ
ajcp-829	31	2	follow	follow	VERB
ajcp-829	31	3	-	-	PUNCT
ajcp-829	31	4	up	up	NOUN
ajcp-829	31	5	a	a	DET
ajcp-829	31	6	week	week	NOUN
ajcp-829	31	7	later	later	ADV
ajcp-829	31	8	,	,	PUNCT
ajcp-829	31	9	a	a	DET
ajcp-829	31	10	patient	patient	NOUN
ajcp-829	31	11	had	have	VERB
ajcp-829	31	12	normal	normal	ADJ
ajcp-829	31	13	kidney	kidney	NOUN
ajcp-829	31	14	functions	function	NOUN
ajcp-829	31	15	and	and	CCONJ
ajcp-829	31	16	was	be	AUX
ajcp-829	31	17	asymptomatic	asymptomatic	ADJ
ajcp-829	31	18	.	.	PUNCT
ajcp-829	32	1	https://doi.org/10.54536/ajcp.v1i2.829	https://doi.org/10.54536/ajcp.v1i2.829	PROPN
ajcp-829	32	2	https://journals.e-palli.com/home/index.php/ajcp	https://journals.e-palli.com/home/index.php/ajcp	PROPN
ajcp-829	32	3	mailto	mailto	PROPN
ajcp-829	32	4	:	:	PUNCT
ajcp-829	32	5	yassersadawey12%40outlook.com?subject=	yassersadawey12%40outlook.com?subject=	PROPN
ajcp-829	32	6	pa	pa	PROPN
ajcp-829	32	7	ge	ge	PROPN
ajcp-829	32	8	6	6	NUM
ajcp-829	32	9	table	table	NOUN
ajcp-829	32	10	1	1	NUM
ajcp-829	32	11	:	:	PUNCT
ajcp-829	32	12	laboratory	laboratory	NOUN
ajcp-829	32	13	values	value	NOUN
ajcp-829	32	14	of	of	ADP
ajcp-829	32	15	admitted	admit	VERB
ajcp-829	32	16	case	case	NOUN
ajcp-829	32	17	normal	normal	ADJ
ajcp-829	32	18	value	value	NOUN
ajcp-829	32	19	feb	feb	PROPN
ajcp-829	32	20	2021	2021	NUM
ajcp-829	32	21	baseline	baseline	VERB
ajcp-829	32	22	2	2	NUM
ajcp-829	32	23	days	day	NOUN
ajcp-829	32	24	pre	pre	X
ajcp-829	32	25	admission	admission	NOUN
ajcp-829	32	26	1	1	NUM
ajcp-829	32	27	day	day	NOUN
ajcp-829	32	28	pre	pre	NOUN
ajcp-829	32	29	admission	admission	NOUN
ajcp-829	32	30	day	day	NOUN
ajcp-829	32	31	1	1	NUM
ajcp-829	32	32	admission	admission	NOUN
ajcp-829	32	33	day	day	NOUN
ajcp-829	32	34	2	2	NUM
ajcp-829	32	35	day	day	NOUN
ajcp-829	32	36	3	3	NUM
ajcp-829	32	37	follow	follow	VERB
ajcp-829	32	38	up	up	ADV
ajcp-829	32	39	in	in	ADP
ajcp-829	32	40	1	1	NUM
ajcp-829	32	41	week	week	NOUN
ajcp-829	32	42	sodium	sodium	NOUN
ajcp-829	32	43	136	136	NUM
ajcp-829	32	44	-	-	SYM
ajcp-829	32	45	145	145	NUM
ajcp-829	32	46	mmol	mmol	NOUN
ajcp-829	32	47	/	/	SYM
ajcp-829	32	48	l	l	NOUN
ajcp-829	32	49	140	140	NUM
ajcp-829	32	50	139	139	NUM
ajcp-829	32	51	139	139	NUM
ajcp-829	32	52	138	138	NUM
ajcp-829	32	53	141	141	NUM
ajcp-829	32	54	140	140	NUM
ajcp-829	32	55	136	136	NUM
ajcp-829	32	56	potassium	potassium	NOUN
ajcp-829	32	57	3.2	3.2	NUM
ajcp-829	32	58	-	-	SYM
ajcp-829	32	59	5.5	5.5	NUM
ajcp-829	32	60	mmol	mmol	NOUN
ajcp-829	32	61	/	/	SYM
ajcp-829	32	62	l	l	NOUN
ajcp-829	32	63	4.3	4.3	NUM
ajcp-829	32	64	4.2	4.2	NUM
ajcp-829	32	65	4.2	4.2	NUM
ajcp-829	32	66	4.2	4.2	NUM
ajcp-829	32	67	3.8	3.8	NUM
ajcp-829	32	68	4.5	4.5	NUM
ajcp-829	32	69	chloride	chloride	NOUN
ajcp-829	32	70	98	98	NUM
ajcp-829	32	71	-	-	SYM
ajcp-829	32	72	107	107	NUM
ajcp-829	32	73	mmol	mmol	NOUN
ajcp-829	32	74	/	/	SYM
ajcp-829	32	75	l	l	NOUN
ajcp-829	32	76	105	105	NUM
ajcp-829	32	77	104	104	NUM
ajcp-829	32	78	103	103	NUM
ajcp-829	32	79	101.4	101.4	NUM
ajcp-829	32	80	106.6	106.6	NUM
ajcp-829	32	81	103.8	103.8	NUM
ajcp-829	32	82	urea	urea	NOUN
ajcp-829	32	83	2.8	2.8	NUM
ajcp-829	32	84	-	-	SYM
ajcp-829	32	85	8.1	8.1	NUM
ajcp-829	32	86	mmol	mmol	NOUN
ajcp-829	32	87	/	/	SYM
ajcp-829	32	88	l	l	NOUN
ajcp-829	32	89	6.3	6.3	NUM
ajcp-829	32	90	4.5	4.5	NUM
ajcp-829	32	91	6.5	6.5	NUM
ajcp-829	32	92	9.1	9.1	NUM
ajcp-829	32	93	6.9	6.9	NUM
ajcp-829	32	94	3.9	3.9	NUM
ajcp-829	32	95	3.7	3.7	NUM
ajcp-829	32	96	creatinine	creatinine	NOUN
ajcp-829	32	97	34	34	NUM
ajcp-829	32	98	-	-	SYM
ajcp-829	32	99	80	80	NUM
ajcp-829	32	100	micrmol	micrmol	NOUN
ajcp-829	32	101	/	/	SYM
ajcp-829	32	102	l	l	NOUN
ajcp-829	32	103	56	56	NUM
ajcp-829	32	104	118	118	NUM
ajcp-829	32	105	231	231	NUM
ajcp-829	32	106	206	206	NUM
ajcp-829	32	107	148	148	NUM
ajcp-829	32	108	82	82	NUM
ajcp-829	32	109	65	65	NUM
ajcp-829	32	110	co3	co3	ADJ
ajcp-829	32	111	22	22	NUM
ajcp-829	32	112	-	-	SYM
ajcp-829	32	113	29	29	NUM
ajcp-829	32	114	mmol	mmol	NOUN
ajcp-829	32	115	/	/	SYM
ajcp-829	32	116	l	l	NOUN
ajcp-829	32	117	26	26	NUM
ajcp-829	32	118	24	24	NUM
ajcp-829	32	119	19	19	NUM
ajcp-829	32	120	ph	ph	NOUN
ajcp-829	32	121	7.35	7.35	NUM
ajcp-829	32	122	-	-	SYM
ajcp-829	32	123	7.45	7.45	NUM
ajcp-829	32	124	na	na	ADP
ajcp-829	32	125	7.35	7.35	NUM
ajcp-829	32	126	7.35	7.35	NUM
ajcp-829	32	127	crp	crp	NOUN
ajcp-829	32	128	<	<	X
ajcp-829	32	129	5mg	5mg	ADJ
ajcp-829	32	130	/	/	SYM
ajcp-829	32	131	l	l	NOUN
ajcp-829	32	132	na	na	ADP
ajcp-829	32	133	5.3	5.3	NUM
ajcp-829	32	134	28.8	28.8	NUM
ajcp-829	32	135	35	35	NUM
ajcp-829	32	136	26	26	NUM
ajcp-829	32	137	10	10	NUM
ajcp-829	32	138	alkaline	alkaline	NOUN
ajcp-829	32	139	phosphatase	phosphatase	NOUN
ajcp-829	32	140	48	48	NUM
ajcp-829	32	141	-	-	SYM
ajcp-829	32	142	95	95	NUM
ajcp-829	32	143	u	u	NOUN
ajcp-829	32	144	/	/	SYM
ajcp-829	32	145	l	l	NOUN
ajcp-829	32	146	109	109	NUM
ajcp-829	32	147	alt	alt	NOUN
ajcp-829	32	148	0	0	NUM
ajcp-829	32	149	-	-	SYM
ajcp-829	32	150	17	17	NUM
ajcp-829	32	151	u	u	NOUN
ajcp-829	32	152	/	/	SYM
ajcp-829	32	153	l	l	PROPN
ajcp-829	32	154	12.2	12.2	NUM
ajcp-829	32	155	11.1	11.1	NUM
ajcp-829	32	156	amylase	amylase	NOUN
ajcp-829	32	157	29	29	NUM
ajcp-829	32	158	-	-	SYM
ajcp-829	32	159	118	118	NUM
ajcp-829	32	160	u	u	NOUN
ajcp-829	32	161	/	/	SYM
ajcp-829	32	162	l	l	NOUN
ajcp-829	32	163	57	57	NUM
ajcp-829	32	164	ast	ast	NOUN
ajcp-829	32	165	0	0	NUM
ajcp-829	32	166	-	-	SYM
ajcp-829	32	167	23	23	NUM
ajcp-829	32	168	u	u	NOUN
ajcp-829	32	169	/	/	SYM
ajcp-829	32	170	l	l	PROPN
ajcp-829	32	171	15.8	15.8	NUM
ajcp-829	32	172	13	13	NUM
ajcp-829	32	173	calcium	calcium	NOUN
ajcp-829	32	174	2.31	2.31	NUM
ajcp-829	32	175	-	-	SYM
ajcp-829	32	176	2.64	2.64	NUM
ajcp-829	32	177	mmol	mmol	NOUN
ajcp-829	32	178	/	/	SYM
ajcp-829	32	179	l	l	NOUN
ajcp-829	32	180	2.35	2.35	NUM
ajcp-829	32	181	tsh	tsh	NOUN
ajcp-829	32	182	0.5	0.5	NUM
ajcp-829	32	183	-	-	SYM
ajcp-829	32	184	4.5	4.5	NUM
ajcp-829	32	185	microiu	microiu	NOUN
ajcp-829	32	186	/	/	SYM
ajcp-829	32	187	ml	ml	PROPN
ajcp-829	32	188	1.89	1.89	NUM
ajcp-829	32	189	hct	hct	NOUN
ajcp-829	32	190	(	(	PUNCT
ajcp-829	32	191	pcv	pcv	NOUN
ajcp-829	32	192	)	)	PUNCT
ajcp-829	32	193	31	31	NUM
ajcp-829	32	194	-	-	SYM
ajcp-829	32	195	42	42	NUM
ajcp-829	32	196	%	%	NOUN
ajcp-829	32	197	32.8	32.8	NUM
ajcp-829	32	198	29.4	29.4	NUM
ajcp-829	32	199	34.9	34.9	NUM
ajcp-829	32	200	haemoglobin	haemoglobin	NOUN
ajcp-829	32	201	10.9	10.9	NUM
ajcp-829	32	202	-	-	SYM
ajcp-829	32	203	14.3	14.3	NUM
ajcp-829	32	204	g	g	NOUN
ajcp-829	32	205	/	/	SYM
ajcp-829	32	206	dl	dl	PROPN
ajcp-829	32	207	10.6	10.6	NUM
ajcp-829	32	208	9.5	9.5	NUM
ajcp-829	32	209	11.2	11.2	NUM
ajcp-829	32	210	basophils	basophil	NOUN
ajcp-829	32	211	%	%	NOUN
ajcp-829	32	212	0.4	0.4	NUM
ajcp-829	32	213	-	-	SYM
ajcp-829	32	214	1.3	1.3	NUM
ajcp-829	32	215	%	%	NOUN
ajcp-829	32	216	0.3	0.3	NUM
ajcp-829	32	217	0.4	0.4	NUM
ajcp-829	32	218	0.5	0.5	NUM
ajcp-829	32	219	eosinophils	eosinophil	NOUN
ajcp-829	32	220	%	%	NOUN
ajcp-829	32	221	0.4	0.4	NUM
ajcp-829	32	222	-	-	SYM
ajcp-829	32	223	8.2	8.2	NUM
ajcp-829	32	224	%	%	NOUN
ajcp-829	32	225	1.2	1.2	NUM
ajcp-829	32	226	2.4	2.4	NUM
ajcp-829	32	227	3.1	3.1	NUM
ajcp-829	32	228	lymphocytes	lymphocyte	NOUN
ajcp-829	32	229	%	%	NOUN
ajcp-829	32	230	20.1	20.1	NUM
ajcp-829	32	231	-	-	SYM
ajcp-829	32	232	48.8	48.8	NUM
ajcp-829	32	233	%	%	NOUN
ajcp-829	32	234	27.6	27.6	NUM
ajcp-829	32	235	28.8	28.8	NUM
ajcp-829	32	236	5.7	5.7	NUM
ajcp-829	32	237	mch	mch	PROPN
ajcp-829	32	238	24.7	24.7	NUM
ajcp-829	32	239	-	-	SYM
ajcp-829	32	240	32.8	32.8	NUM
ajcp-829	32	241	pg	pg	NOUN
ajcp-829	32	242	23	23	NUM
ajcp-829	32	243	22.9	22.9	NUM
ajcp-829	32	244	23.2	23.2	NUM
ajcp-829	32	245	mchc	mchc	NOUN
ajcp-829	32	246	32.3	32.3	NUM
ajcp-829	32	247	-	-	SYM
ajcp-829	32	248	35.6g	35.6g	NUM
ajcp-829	32	249	/	/	SYM
ajcp-829	32	250	dl	dl	PROPN
ajcp-829	32	251	32.3	32.3	NUM
ajcp-829	32	252	32.4	32.4	NUM
ajcp-829	32	253	32	32	NUM
ajcp-829	32	254	mcv	mcv	PROPN
ajcp-829	32	255	75.5	75.5	NUM
ajcp-829	32	256	-	-	SYM
ajcp-829	32	257	95.3	95.3	NUM
ajcp-829	32	258	fl	fl	NOUN
ajcp-829	32	259	71.3	71.3	NUM
ajcp-829	32	260	70.7	70.7	NUM
ajcp-829	32	261	72.4	72.4	NUM
ajcp-829	32	262	monocytes	monocyte	VERB
ajcp-829	32	263	%	%	NOUN
ajcp-829	32	264	4.10	4.10	NUM
ajcp-829	32	265	-	-	SYM
ajcp-829	32	266	12.90	12.90	NUM
ajcp-829	32	267	%	%	NOUN
ajcp-829	32	268	11.3	11.3	NUM
ajcp-829	32	269	13	13	NUM
ajcp-829	32	270	10.3	10.3	NUM
ajcp-829	32	271	neutrophils	neutrophil	NOUN
ajcp-829	32	272	%	%	VERB
ajcp-829	32	273	42.8	42.8	NUM
ajcp-829	32	274	-	-	SYM
ajcp-829	32	275	75.1	75.1	NUM
ajcp-829	32	276	%	%	NOUN
ajcp-829	32	277	59.6	59.6	NUM
ajcp-829	32	278	55.4	55.4	NUM
ajcp-829	32	279	80.4	80.4	NUM
ajcp-829	32	280	platelet	platelet	NOUN
ajcp-829	32	281	count	count	NOUN
ajcp-829	32	282	150	150	NUM
ajcp-829	32	283	-	-	SYM
ajcp-829	32	284	410	410	NUM
ajcp-829	32	285	10³/ųl	10³/ųl	NUM
ajcp-829	32	286	249	249	NUM
ajcp-829	32	287	237	237	NUM
ajcp-829	32	288	264	264	NUM
ajcp-829	32	289	red	red	ADJ
ajcp-829	32	290	cell	cell	NOUN
ajcp-829	32	291	count	count	NOUN
ajcp-829	32	292	3.63	3.63	NUM
ajcp-829	32	293	-	-	SYM
ajcp-829	32	294	4.92	4.92	NUM
ajcp-829	32	295	10⁶/ųl	10⁶/ųl	NUM
ajcp-829	32	296	4.6	4.6	NUM
ajcp-829	32	297	4.15	4.15	NUM
ajcp-829	32	298	4.82	4.82	NUM
ajcp-829	32	299	white	white	ADJ
ajcp-829	32	300	cell	cell	NOUN
ajcp-829	32	301	count	count	VERB
ajcp-829	32	302	3.8	3.8	NUM
ajcp-829	32	303	-	-	SYM
ajcp-829	32	304	11.8	11.8	NUM
ajcp-829	32	305	10⁶/ųl	10⁶/ųl	NUM
ajcp-829	32	306	6.7	6.7	NUM
ajcp-829	32	307	6.2	6.2	NUM
ajcp-829	32	308	7.4	7.4	NUM
ajcp-829	32	309	urine	urine	NOUN
ajcp-829	32	310	rotine	rotine	VERB
ajcp-829	32	311	blood	blood	NOUN
ajcp-829	32	312	(	(	PUNCT
ajcp-829	32	313	rbc	rbc	PROPN
ajcp-829	32	314	)	)	PUNCT
ajcp-829	32	315	negative	negative	ADJ
ajcp-829	32	316	negative	negative	ADJ
ajcp-829	32	317	negative	negative	ADJ
ajcp-829	32	318	ketone	ketone	NOUN
ajcp-829	32	319	negative	negative	ADJ
ajcp-829	32	320	positive	positive	ADJ
ajcp-829	32	321	+	+	CCONJ
ajcp-829	32	322	negative	negative	ADJ
ajcp-829	32	323	protein	protein	NOUN
ajcp-829	32	324	negative	negative	ADJ
ajcp-829	32	325	negative	negative	ADJ
ajcp-829	32	326	10	10	NUM
ajcp-829	32	327	mg	mg	PROPN
ajcp-829	32	328	/	/	SYM
ajcp-829	32	329	dl	dl	X
ajcp-829	32	330	amorphous	amorphous	ADJ
ajcp-829	32	331	urate	urate	NOUN
ajcp-829	32	332	nil	nil	NOUN
ajcp-829	32	333	nil	nil	NOUN
ajcp-829	32	334	nil	nil	ADJ
ajcp-829	32	335	amorphous	amorphous	ADJ
ajcp-829	32	336	phosphate	phosphate	NOUN
ajcp-829	32	337	nil	nil	NOUN
ajcp-829	32	338	nil	nil	NOUN
ajcp-829	32	339	nil	nil	NOUN
ajcp-829	32	340	bilirubin	bilirubin	NOUN
ajcp-829	32	341	negative	negative	ADJ
ajcp-829	32	342	negative	negative	ADJ
ajcp-829	32	343	negative	negative	ADJ
ajcp-829	32	344	crystals	crystal	NOUN
ajcp-829	32	345	nil	nil	NOUN
ajcp-829	32	346	nil	nil	NOUN
ajcp-829	32	347	nil	nil	NOUN
ajcp-829	32	348	fatty	fatty	NOUN
ajcp-829	32	349	casts	cast	NOUN
ajcp-829	32	350	nil	nil	NOUN
ajcp-829	32	351	nil	nil	ADJ
ajcp-829	32	352	nil	nil	NOUN
ajcp-829	32	353	granular	granular	ADJ
ajcp-829	32	354	casts	cast	NOUN
ajcp-829	32	355	nil	nil	NOUN
ajcp-829	32	356	nil	nil	ADJ
ajcp-829	32	357	nil	nil	NOUN
ajcp-829	32	358	hyaline	hyaline	NOUN
ajcp-829	32	359	casts	cast	VERB
ajcp-829	32	360	nil	nil	NOUN
ajcp-829	32	361	nil	nil	ADJ
ajcp-829	32	362	nil	nil	NOUN
ajcp-829	32	363	pa	pa	PROPN
ajcp-829	32	364	ge	ge	PROPN
ajcp-829	32	365	7	7	NUM
ajcp-829	32	366	rbc	rbc	PROPN
ajcp-829	32	367	casts	cast	VERB
ajcp-829	32	368	nil	nil	PROPN
ajcp-829	32	369	nil	nil	ADJ
ajcp-829	32	370	nil	nil	NOUN
ajcp-829	32	371	wbc	wbc	PROPN
ajcp-829	32	372	casts	cast	VERB
ajcp-829	32	373	nil	nil	NOUN
ajcp-829	32	374	nil	nil	ADJ
ajcp-829	32	375	nil	nil	NOUN
ajcp-829	32	376	glucose	glucose	NOUN
ajcp-829	32	377	negative	negative	ADJ
ajcp-829	32	378	negative	negative	ADJ
ajcp-829	32	379	negative	negative	ADJ
ajcp-829	32	380	leukocytes	leukocyte	NOUN
ajcp-829	32	381	0	0	NUM
ajcp-829	32	382	-	-	SYM
ajcp-829	32	383	5	5	NUM
ajcp-829	32	384	cell	cell	NOUN
ajcp-829	32	385	/	/	SYM
ajcp-829	32	386	hpf	hpf	NOUN
ajcp-829	32	387	10	10	NUM
ajcp-829	32	388	-	-	PUNCT
ajcp-829	32	389	jun	jun	PROPN
ajcp-829	32	390	0	0	NUM
ajcp-829	32	391	-	-	SYM
ajcp-829	32	392	5	5	NUM
ajcp-829	32	393	leukocyte	leukocyte	NOUN
ajcp-829	32	394	esterase	esterase	NOUN
ajcp-829	32	395	negative	negative	ADJ
ajcp-829	32	396	positive	positive	ADJ
ajcp-829	32	397	+	+	CCONJ
ajcp-829	32	398	negative	negative	ADJ
ajcp-829	32	399	nitrite	nitrite	NOUN
ajcp-829	32	400	negative	negative	ADJ
ajcp-829	32	401	negative	negative	ADJ
ajcp-829	32	402	negative	negative	ADJ
ajcp-829	32	403	ph	ph	ADJ
ajcp-829	32	404	5	5	NUM
ajcp-829	32	405	-	-	SYM
ajcp-829	32	406	9	9	NUM
ajcp-829	32	407	ph	ph	NOUN
ajcp-829	32	408	5	5	NUM
ajcp-829	32	409	6	6	NUM
ajcp-829	32	410	bacteria	bacteria	NOUN
ajcp-829	32	411	nil	nil	NOUN
ajcp-829	32	412	few	few	ADJ
ajcp-829	32	413	+	+	ADJ
ajcp-829	32	414	+	+	ADJ
ajcp-829	32	415	nil	nil	ADJ
ajcp-829	32	416	specific	specific	ADJ
ajcp-829	32	417	gravity	gravity	NOUN
ajcp-829	32	418	1.003	1.003	NUM
ajcp-829	32	419	1.035	1.035	NUM
ajcp-829	32	420	1.01	1.01	NUM
ajcp-829	32	421	1.009	1.009	NUM
ajcp-829	32	422	discussion	discussion	NOUN
ajcp-829	32	423	nephropathy	nephropathy	NOUN
ajcp-829	32	424	caused	cause	VERB
ajcp-829	32	425	by	by	ADP
ajcp-829	32	426	oral	oral	ADJ
ajcp-829	32	427	acyclovir	acyclovir	PROPN
ajcp-829	32	428	is	be	AUX
ajcp-829	32	429	uncommon	uncommon	ADJ
ajcp-829	32	430	and	and	CCONJ
ajcp-829	32	431	only	only	ADV
ajcp-829	32	432	manifests	manifest	VERB
ajcp-829	32	433	itself	itself	PRON
ajcp-829	32	434	at	at	ADP
ajcp-829	32	435	very	very	ADV
ajcp-829	32	436	high	high	ADJ
ajcp-829	32	437	doses	dose	NOUN
ajcp-829	32	438	(	(	PUNCT
ajcp-829	32	439	more	more	ADJ
ajcp-829	32	440	than	than	ADP
ajcp-829	32	441	500	500	NUM
ajcp-829	32	442	mg	mg	NUM
ajcp-829	32	443	/	/	SYM
ajcp-829	32	444	m2	m2	PROPN
ajcp-829	32	445	)	)	PUNCT
ajcp-829	32	446	when	when	SCONJ
ajcp-829	32	447	the	the	DET
ajcp-829	32	448	medication	medication	NOUN
ajcp-829	32	449	is	be	AUX
ajcp-829	32	450	used	use	VERB
ajcp-829	32	451	by	by	ADP
ajcp-829	32	452	patients	patient	NOUN
ajcp-829	32	453	whose	whose	DET
ajcp-829	32	454	volume	volume	NOUN
ajcp-829	32	455	status	status	NOUN
ajcp-829	32	456	has	have	AUX
ajcp-829	32	457	significantly	significantly	ADV
ajcp-829	32	458	reduced	reduce	VERB
ajcp-829	32	459	(	(	PUNCT
ajcp-829	32	460	perazella	perazella	NOUN
ajcp-829	32	461	.	.	PUNCT
ajcp-829	32	462	,	,	PUNCT
ajcp-829	32	463	1999	1999	NUM
ajcp-829	32	464	)	)	PUNCT
ajcp-829	32	465	.	.	PUNCT
ajcp-829	33	1	it	it	PRON
ajcp-829	33	2	is	be	AUX
ajcp-829	33	3	critical	critical	ADJ
ajcp-829	33	4	to	to	PART
ajcp-829	33	5	know	know	VERB
ajcp-829	33	6	the	the	DET
ajcp-829	33	7	possible	possible	ADJ
ajcp-829	33	8	nephrotoxicity	nephrotoxicity	NOUN
ajcp-829	33	9	for	for	SCONJ
ajcp-829	33	10	the	the	DET
ajcp-829	33	11	patients	patient	NOUN
ajcp-829	33	12	being	be	AUX
ajcp-829	33	13	treated	treat	VERB
ajcp-829	33	14	with	with	ADP
ajcp-829	33	15	acyclovir	acyclovir	PROPN
ajcp-829	33	16	.	.	PUNCT
ajcp-829	34	1	our	our	PRON
ajcp-829	34	2	patient	patient	NOUN
ajcp-829	34	3	had	have	VERB
ajcp-829	34	4	an	an	DET
ajcp-829	34	5	acute	acute	ADJ
ajcp-829	34	6	kidney	kidney	NOUN
ajcp-829	34	7	injury	injury	NOUN
ajcp-829	34	8	while	while	SCONJ
ajcp-829	34	9	taking	take	VERB
ajcp-829	34	10	oral	oral	ADJ
ajcp-829	34	11	acyclovir	acyclovir	NOUN
ajcp-829	34	12	and	and	CCONJ
ajcp-829	34	13	other	other	ADJ
ajcp-829	34	14	nephrotoxic	nephrotoxic	ADJ
ajcp-829	34	15	drugs	drug	NOUN
ajcp-829	34	16	and	and	CCONJ
ajcp-829	34	17	being	be	AUX
ajcp-829	34	18	volume	volume	NOUN
ajcp-829	34	19	depleted	deplete	VERB
ajcp-829	34	20	,	,	PUNCT
ajcp-829	34	21	but	but	CCONJ
ajcp-829	34	22	her	her	PRON
ajcp-829	34	23	creatinine	creatinine	NOUN
ajcp-829	34	24	improved	improve	VERB
ajcp-829	34	25	when	when	SCONJ
ajcp-829	34	26	acyclovir	acyclovir	PROPN
ajcp-829	34	27	stopped	stop	VERB
ajcp-829	34	28	therefore	therefore	ADV
ajcp-829	34	29	,	,	PUNCT
ajcp-829	34	30	acyclovir	acyclovir	PROPN
ajcp-829	34	31	crystalluria	crystalluria	PROPN
ajcp-829	34	32	and	and	CCONJ
ajcp-829	34	33	subsequent	subsequent	ADJ
ajcp-829	34	34	intrarenal	intrarenal	ADJ
ajcp-829	34	35	obstruction	obstruction	NOUN
ajcp-829	34	36	and	and	CCONJ
ajcp-829	34	37	nephropathy	nephropathy	NOUN
ajcp-829	34	38	would	would	AUX
ajcp-829	34	39	be	be	AUX
ajcp-829	34	40	the	the	DET
ajcp-829	34	41	most	most	ADV
ajcp-829	34	42	plausible	plausible	ADJ
ajcp-829	34	43	explanation	explanation	NOUN
ajcp-829	34	44	for	for	ADP
ajcp-829	34	45	the	the	DET
ajcp-829	34	46	observed	observe	VERB
ajcp-829	34	47	renal	renal	ADJ
ajcp-829	34	48	injury	injury	NOUN
ajcp-829	34	49	,	,	PUNCT
ajcp-829	34	50	even	even	ADV
ajcp-829	34	51	if	if	SCONJ
ajcp-829	34	52	the	the	DET
ajcp-829	34	53	crystals	crystal	NOUN
ajcp-829	34	54	were	be	AUX
ajcp-829	34	55	undetected	undetecte	VERB
ajcp-829	34	56	on	on	ADP
ajcp-829	34	57	regular	regular	ADJ
ajcp-829	34	58	urine	urine	NOUN
ajcp-829	34	59	analysis	analysis	NOUN
ajcp-829	34	60	.	.	PUNCT
ajcp-829	35	1	in	in	ADP
ajcp-829	35	2	individuals	individual	NOUN
ajcp-829	35	3	with	with	ADP
ajcp-829	35	4	underlying	underlying	ADJ
ajcp-829	35	5	volume	volume	NOUN
ajcp-829	35	6	depletion	depletion	NOUN
ajcp-829	35	7	and	and	CCONJ
ajcp-829	35	8	renal	renal	ADJ
ajcp-829	35	9	insufficiency	insufficiency	NOUN
ajcp-829	35	10	,	,	PUNCT
ajcp-829	35	11	acyclovir	acyclovir	PROPN
ajcp-829	35	12	dosage	dosage	NOUN
ajcp-829	35	13	should	should	AUX
ajcp-829	35	14	be	be	AUX
ajcp-829	35	15	lowered	lower	VERB
ajcp-829	35	16	.	.	PUNCT
ajcp-829	36	1	to	to	PART
ajcp-829	36	2	avoid	avoid	VERB
ajcp-829	36	3	crystallisation	crystallisation	NOUN
ajcp-829	36	4	and	and	CCONJ
ajcp-829	36	5	eventual	eventual	ADJ
ajcp-829	36	6	tubular	tubular	ADJ
ajcp-829	36	7	blockage	blockage	NOUN
ajcp-829	36	8	,	,	PUNCT
ajcp-829	36	9	gradual	gradual	ADJ
ajcp-829	36	10	medication	medication	NOUN
ajcp-829	36	11	infusion	infusion	NOUN
ajcp-829	36	12	over	over	ADP
ajcp-829	36	13	1	1	NUM
ajcp-829	36	14	-	-	SYM
ajcp-829	36	15	2	2	NUM
ajcp-829	36	16	hours	hour	NOUN
ajcp-829	36	17	,	,	PUNCT
ajcp-829	36	18	appropriate	appropriate	ADJ
ajcp-829	36	19	fluid	fluid	ADJ
ajcp-829	36	20	replenishment	replenishment	NOUN
ajcp-829	36	21	,	,	PUNCT
ajcp-829	36	22	and	and	CCONJ
ajcp-829	36	23	introduction	introduction	NOUN
ajcp-829	36	24	of	of	ADP
ajcp-829	36	25	high	high	ADJ
ajcp-829	36	26	urine	urine	NOUN
ajcp-829	36	27	flow	flow	NOUN
ajcp-829	36	28	rates	rate	NOUN
ajcp-829	36	29	(	(	PUNCT
ajcp-829	36	30	100	100	NUM
ajcp-829	36	31	-	-	SYM
ajcp-829	36	32	150	150	NUM
ajcp-829	36	33	ml	ml	NOUN
ajcp-829	36	34	/	/	SYM
ajcp-829	36	35	h	h	NOUN
ajcp-829	36	36	)	)	PUNCT
ajcp-829	36	37	should	should	AUX
ajcp-829	36	38	be	be	AUX
ajcp-829	36	39	recommended	recommend	VERB
ajcp-829	36	40	(	(	PUNCT
ajcp-829	36	41	brigden	brigden	VERB
ajcp-829	36	42	et	et	PROPN
ajcp-829	36	43	al	al	PROPN
ajcp-829	36	44	.	.	PROPN
ajcp-829	36	45	,	,	PUNCT
ajcp-829	36	46	1982	1982	NUM
ajcp-829	36	47	;	;	PUNCT
ajcp-829	37	1	sawyer	sawyer	PROPN
ajcp-829	37	2	et	et	PROPN
ajcp-829	37	3	al	al	PROPN
ajcp-829	37	4	.	.	PROPN
ajcp-829	37	5	,	,	PUNCT
ajcp-829	37	6	1988	1988	NUM
ajcp-829	37	7	)	)	PUNCT
ajcp-829	37	8	.	.	PUNCT
ajcp-829	38	1	renal	renal	ADJ
ajcp-829	38	2	function	function	NOUN
ajcp-829	38	3	should	should	AUX
ajcp-829	38	4	be	be	AUX
ajcp-829	38	5	monitored	monitor	VERB
ajcp-829	38	6	regularly	regularly	ADV
ajcp-829	38	7	in	in	ADP
ajcp-829	38	8	patients	patient	NOUN
ajcp-829	38	9	receiving	receive	VERB
ajcp-829	38	10	high	high	ADJ
ajcp-829	38	11	-	-	PUNCT
ajcp-829	38	12	dose	dose	NOUN
ajcp-829	38	13	intravenous	intravenous	ADJ
ajcp-829	38	14	acyclovir	acyclovir	PROPN
ajcp-829	38	15	in	in	ADP
ajcp-829	38	16	patients	patient	NOUN
ajcp-829	38	17	diagnosed	diagnose	VERB
ajcp-829	38	18	with	with	ADP
ajcp-829	38	19	renal	renal	ADJ
ajcp-829	38	20	impairment	impairment	NOUN
ajcp-829	38	21	at	at	ADP
ajcp-829	38	22	any	any	DET
ajcp-829	38	23	dosage	dosage	NOUN
ajcp-829	38	24	level	level	NOUN
ajcp-829	38	25	.	.	PUNCT
ajcp-829	39	1	common	common	ADJ
ajcp-829	39	2	symptoms	symptom	NOUN
ajcp-829	39	3	include	include	VERB
ajcp-829	39	4	unusual	unusual	ADJ
ajcp-829	39	5	sickness	sickness	NOUN
ajcp-829	39	6	,	,	PUNCT
ajcp-829	39	7	nausea	nausea	NOUN
ajcp-829	39	8	,	,	PUNCT
ajcp-829	39	9	abdominal	abdominal	ADJ
ajcp-829	39	10	discomfort	discomfort	NOUN
ajcp-829	39	11	,	,	PUNCT
ajcp-829	39	12	vomiting	vomiting	NOUN
ajcp-829	39	13	,	,	PUNCT
ajcp-829	39	14	and	and	CCONJ
ajcp-829	39	15	muscle	muscle	NOUN
ajcp-829	39	16	twitching	twitch	VERB
ajcp-829	39	17	while	while	SCONJ
ajcp-829	39	18	receiving	receive	VERB
ajcp-829	39	19	treatment	treatment	NOUN
ajcp-829	39	20	(	(	PUNCT
ajcp-829	39	21	wade	wade	PROPN
ajcp-829	39	22	jc	jc	PROPN
ajcp-829	39	23	,	,	PUNCT
ajcp-829	39	24	1983	1983	NUM
ajcp-829	39	25	)	)	PUNCT
ajcp-829	39	26	.	.	PUNCT
ajcp-829	40	1	when	when	SCONJ
ajcp-829	40	2	serum	serum	NOUN
ajcp-829	40	3	creatinine	creatinine	NOUN
ajcp-829	40	4	levels	level	NOUN
ajcp-829	40	5	rise	rise	VERB
ajcp-829	40	6	,	,	PUNCT
ajcp-829	40	7	acyclovir	acyclovir	PROPN
ajcp-829	40	8	must	must	AUX
ajcp-829	40	9	be	be	AUX
ajcp-829	40	10	managed	manage	VERB
ajcp-829	40	11	to	to	PART
ajcp-829	40	12	be	be	AUX
ajcp-829	40	13	discontinued	discontinue	VERB
ajcp-829	40	14	.	.	PUNCT
ajcp-829	41	1	hydration	hydration	NOUN
ajcp-829	41	2	should	should	AUX
ajcp-829	41	3	be	be	AUX
ajcp-829	41	4	maintained	maintain	VERB
ajcp-829	41	5	during	during	ADP
ajcp-829	41	6	therapy	therapy	NOUN
ajcp-829	41	7	to	to	PART
ajcp-829	41	8	ensure	ensure	VERB
ajcp-829	41	9	a	a	DET
ajcp-829	41	10	high	high	ADJ
ajcp-829	41	11	urine	urine	NOUN
ajcp-829	41	12	flow(gunness	flow(gunness	ADJ
ajcp-829	41	13	p	p	X
ajcp-829	41	14	,	,	PUNCT
ajcp-829	41	15	2010	2010	NUM
ajcp-829	41	16	)	)	PUNCT
ajcp-829	41	17	.	.	PUNCT
ajcp-829	42	1	if	if	SCONJ
ajcp-829	42	2	no	no	DET
ajcp-829	42	3	improvement	improvement	NOUN
ajcp-829	42	4	is	be	AUX
ajcp-829	42	5	observed	observe	VERB
ajcp-829	42	6	in	in	ADP
ajcp-829	42	7	patients	patient	NOUN
ajcp-829	42	8	with	with	ADP
ajcp-829	42	9	renal	renal	ADJ
ajcp-829	42	10	function	function	NOUN
ajcp-829	42	11	soon	soon	ADV
ajcp-829	42	12	after	after	ADP
ajcp-829	42	13	discontinuing	discontinue	VERB
ajcp-829	42	14	acyclovir	acyclovir	PROPN
ajcp-829	42	15	,	,	PUNCT
ajcp-829	42	16	other	other	ADJ
ajcp-829	42	17	causes	cause	NOUN
ajcp-829	42	18	of	of	ADP
ajcp-829	42	19	renal	renal	ADJ
ajcp-829	42	20	toxicity	toxicity	NOUN
ajcp-829	42	21	should	should	AUX
ajcp-829	42	22	be	be	AUX
ajcp-829	42	23	sought	seek	VERB
ajcp-829	42	24	.	.	PUNCT
ajcp-829	43	1	treatment	treatment	NOUN
ajcp-829	43	2	may	may	AUX
ajcp-829	43	3	be	be	AUX
ajcp-829	43	4	maintained	maintain	VERB
ajcp-829	43	5	at	at	ADP
ajcp-829	43	6	a	a	DET
ajcp-829	43	7	lower	low	ADJ
ajcp-829	43	8	dose	dose	NOUN
ajcp-829	43	9	for	for	ADP
ajcp-829	43	10	secondary	secondary	ADJ
ajcp-829	43	11	infections	infection	NOUN
ajcp-829	43	12	that	that	PRON
ajcp-829	43	13	respond	respond	VERB
ajcp-829	43	14	to	to	ADP
ajcp-829	43	15	acyclovir	acyclovir	PROPN
ajcp-829	43	16	while	while	SCONJ
ajcp-829	43	17	a	a	DET
ajcp-829	43	18	renal	renal	ADJ
ajcp-829	43	19	function	function	NOUN
ajcp-829	43	20	is	be	AUX
ajcp-829	43	21	closely	closely	ADV
ajcp-829	43	22	monitored	monitor	VERB
ajcp-829	43	23	.	.	PUNCT
ajcp-829	44	1	since	since	SCONJ
ajcp-829	44	2	volume	volume	NOUN
ajcp-829	44	3	contraction	contraction	NOUN
ajcp-829	44	4	may	may	AUX
ajcp-829	44	5	go	go	VERB
ajcp-829	44	6	undiagnosed	undiagnosed	ADJ
ajcp-829	44	7	in	in	ADP
ajcp-829	44	8	outpatients	outpatient	NOUN
ajcp-829	44	9	treated	treat	VERB
ajcp-829	44	10	with	with	ADP
ajcp-829	44	11	acyclovir	acyclovir	PROPN
ajcp-829	44	12	,	,	PUNCT
ajcp-829	44	13	they	they	PRON
ajcp-829	44	14	are	be	AUX
ajcp-829	44	15	more	more	ADV
ajcp-829	44	16	susceptible	susceptible	ADJ
ajcp-829	44	17	to	to	ADP
ajcp-829	44	18	acyclovirinduced	acyclovirinduce	VERB
ajcp-829	44	19	kidney	kidney	PROPN
ajcp-829	44	20	damage(chawla	damage(chawla	PROPN
ajcp-829	44	21	,	,	PUNCT
ajcp-829	44	22	2017	2017	NUM
ajcp-829	44	23	)	)	PUNCT
ajcp-829	44	24	.	.	PUNCT
ajcp-829	45	1	conclusion	conclusion	NOUN
ajcp-829	45	2	it	it	PRON
ajcp-829	45	3	is	be	AUX
ajcp-829	45	4	concluded	conclude	VERB
ajcp-829	45	5	that	that	SCONJ
ajcp-829	45	6	to	to	PART
ajcp-829	45	7	prevent	prevent	VERB
ajcp-829	45	8	morbidity	morbidity	NOUN
ajcp-829	45	9	,	,	PUNCT
ajcp-829	45	10	acute	acute	ADJ
ajcp-829	45	11	kidney	kidney	NOUN
ajcp-829	45	12	injury	injury	NOUN
ajcp-829	45	13	must	must	AUX
ajcp-829	45	14	be	be	AUX
ajcp-829	45	15	diagnosed	diagnose	VERB
ajcp-829	45	16	as	as	ADV
ajcp-829	45	17	soon	soon	ADV
ajcp-829	45	18	as	as	ADP
ajcp-829	45	19	possible	possible	ADJ
ajcp-829	45	20	(	(	PUNCT
ajcp-829	45	21	ratan	ratan	PROPN
ajcp-829	45	22	.	.	PROPN
ajcp-829	45	23	,	,	PUNCT
ajcp-829	45	24	2003	2003	NUM
ajcp-829	45	25	)	)	PUNCT
ajcp-829	45	26	.	.	PUNCT
ajcp-829	46	1	since	since	SCONJ
ajcp-829	46	2	acyclovir	acyclovir	PROPN
ajcp-829	46	3	is	be	AUX
ajcp-829	46	4	frequently	frequently	ADV
ajcp-829	46	5	prescribed	prescribe	VERB
ajcp-829	46	6	for	for	ADP
ajcp-829	46	7	renal	renal	ADJ
ajcp-829	46	8	transplantation	transplantation	NOUN
ajcp-829	46	9	,	,	PUNCT
ajcp-829	46	10	patients	patient	NOUN
ajcp-829	46	11	with	with	ADP
ajcp-829	46	12	herpes	herpe	NOUN
ajcp-829	46	13	simplex	simplex	NOUN
ajcp-829	46	14	virus	virus	NOUN
ajcp-829	46	15	and	and	CCONJ
ajcp-829	46	16	herpes	herpe	NOUN
ajcp-829	46	17	zoster	zoster	NOUN
ajcp-829	46	18	infections	infection	NOUN
ajcp-829	46	19	,	,	PUNCT
ajcp-829	46	20	and	and	CCONJ
ajcp-829	46	21	patients	patient	NOUN
ajcp-829	46	22	with	with	ADP
ajcp-829	46	23	neurological	neurological	ADJ
ajcp-829	46	24	viral	viral	ADJ
ajcp-829	46	25	infections	infection	NOUN
ajcp-829	46	26	,	,	PUNCT
ajcp-829	46	27	therefore	therefore	ADV
ajcp-829	46	28	,	,	PUNCT
ajcp-829	46	29	practitioners	practitioner	NOUN
ajcp-829	46	30	must	must	AUX
ajcp-829	46	31	be	be	AUX
ajcp-829	46	32	aware	aware	ADJ
ajcp-829	46	33	of	of	ADP
ajcp-829	46	34	the	the	DET
ajcp-829	46	35	associated	associated	ADJ
ajcp-829	46	36	risk	risk	NOUN
ajcp-829	46	37	,	,	PUNCT
ajcp-829	46	38	side	side	NOUN
ajcp-829	46	39	effects	effect	NOUN
ajcp-829	46	40	,	,	PUNCT
ajcp-829	46	41	and	and	CCONJ
ajcp-829	46	42	how	how	SCONJ
ajcp-829	46	43	drug	drug	NOUN
ajcp-829	46	44	-	-	PUNCT
ajcp-829	46	45	related	relate	VERB
ajcp-829	46	46	issues	issue	NOUN
ajcp-829	46	47	might	might	AUX
ajcp-829	46	48	be	be	AUX
ajcp-829	46	49	addressed	address	VERB
ajcp-829	46	50	.	.	PUNCT
ajcp-829	47	1	ethical	ethical	ADJ
ajcp-829	47	2	approval	approval	NOUN
ajcp-829	47	3	ethical	ethical	ADJ
ajcp-829	47	4	approval	approval	NOUN
ajcp-829	47	5	for	for	ADP
ajcp-829	47	6	this	this	DET
ajcp-829	47	7	study	study	NOUN
ajcp-829	47	8	was	be	AUX
ajcp-829	47	9	obtained	obtain	VERB
ajcp-829	47	10	from	from	ADP
ajcp-829	47	11	mediclinic	mediclinic	PROPN
ajcp-829	47	12	al	al	PROPN
ajcp-829	47	13	jowhara	jowhara	PROPN
ajcp-829	47	14	hospital	hospital	PROPN
ajcp-829	47	15	(	(	PUNCT
ajcp-829	47	16	reference	reference	NOUN
ajcp-829	47	17	number	number	NOUN
ajcp-829	47	18	:	:	PUNCT
ajcp-829	47	19	uhn	uhn	PROPN
ajcp-829	47	20	:	:	PUNCT
ajcp-829	47	21	1238416	1238416	NUM
ajcp-829	47	22	)	)	PUNCT
ajcp-829	47	23	.	.	PUNCT
ajcp-829	48	1	all	all	DET
ajcp-829	48	2	procedures	procedure	NOUN
ajcp-829	48	3	performed	perform	VERB
ajcp-829	48	4	in	in	ADP
ajcp-829	48	5	the	the	DET
ajcp-829	48	6	study	study	NOUN
ajcp-829	48	7	involving	involve	VERB
ajcp-829	48	8	the	the	DET
ajcp-829	48	9	patient	patient	NOUN
ajcp-829	48	10	were	be	AUX
ajcp-829	48	11	by	by	ADP
ajcp-829	48	12	the	the	DET
ajcp-829	48	13	ethical	ethical	ADJ
ajcp-829	48	14	standards	standard	NOUN
ajcp-829	48	15	of	of	ADP
ajcp-829	48	16	the	the	DET
ajcp-829	48	17	governmental	governmental	ADJ
ajcp-829	48	18	guidelines	guideline	NOUN
ajcp-829	48	19	and	and	CCONJ
ajcp-829	48	20	with	with	ADP
ajcp-829	48	21	the	the	DET
ajcp-829	48	22	1964	1964	NUM
ajcp-829	48	23	helsinki	helsinki	PROPN
ajcp-829	48	24	declaration	declaration	PROPN
ajcp-829	48	25	and	and	CCONJ
ajcp-829	48	26	its	its	PRON
ajcp-829	48	27	later	later	ADJ
ajcp-829	48	28	amendments	amendment	NOUN
ajcp-829	48	29	or	or	CCONJ
ajcp-829	48	30	comparable	comparable	ADJ
ajcp-829	48	31	ethical	ethical	ADJ
ajcp-829	48	32	standards	standard	NOUN
ajcp-829	48	33	.	.	PUNCT
ajcp-829	49	1	conflict	conflict	NOUN
ajcp-829	49	2	of	of	ADP
ajcp-829	49	3	interest	interest	NOUN
ajcp-829	49	4	the	the	DET
ajcp-829	49	5	authors	author	NOUN
ajcp-829	49	6	declare	declare	VERB
ajcp-829	49	7	that	that	SCONJ
ajcp-829	49	8	there	there	PRON
ajcp-829	49	9	is	be	VERB
ajcp-829	49	10	no	no	DET
ajcp-829	49	11	conflict	conflict	NOUN
ajcp-829	49	12	of	of	ADP
ajcp-829	49	13	interest	interest	NOUN
ajcp-829	49	14	regarding	regard	VERB
ajcp-829	49	15	the	the	DET
ajcp-829	49	16	publication	publication	NOUN
ajcp-829	49	17	of	of	ADP
ajcp-829	49	18	this	this	DET
ajcp-829	49	19	case	case	NOUN
ajcp-829	49	20	report	report	NOUN
ajcp-829	49	21	.	.	PUNCT
ajcp-829	50	1	funding	fund	VERB
ajcp-829	50	2	any	any	DET
ajcp-829	50	3	grants	grant	NOUN
ajcp-829	50	4	did	do	AUX
ajcp-829	50	5	not	not	PART
ajcp-829	50	6	fund	fund	VERB
ajcp-829	50	7	this	this	DET
ajcp-829	50	8	work	work	NOUN
ajcp-829	50	9	.	.	PUNCT
ajcp-829	51	1	informed	inform	VERB
ajcp-829	51	2	consent	consent	NOUN
ajcp-829	51	3	written	write	VERB
ajcp-829	51	4	informed	inform	VERB
ajcp-829	51	5	consent	consent	NOUN
ajcp-829	51	6	was	be	AUX
ajcp-829	51	7	obtained	obtain	VERB
ajcp-829	51	8	from	from	ADP
ajcp-829	51	9	the	the	DET
ajcp-829	51	10	participant	participant	NOUN
ajcp-829	51	11	.	.	PUNCT
ajcp-829	52	1	reference	reference	NOUN
ajcp-829	52	2	balfour	balfour	PROPN
ajcp-829	52	3	h.	h.	PROPN
ajcp-829	52	4	h.	h.	PROPN
ajcp-829	52	5	,	,	PUNCT
ajcp-829	52	6	j.	j.	PROPN
ajcp-829	52	7	(	(	PUNCT
ajcp-829	52	8	1984	1984	NUM
ajcp-829	52	9	)	)	PUNCT
ajcp-829	52	10	.	.	PUNCT
ajcp-829	53	1	intravenous	intravenous	ADJ
ajcp-829	53	2	acyclovir	acyclovir	PROPN
ajcp-829	53	3	therapy	therapy	NOUN
ajcp-829	53	4	for	for	ADP
ajcp-829	53	5	varicella	varicella	NOUN
ajcp-829	53	6	in	in	ADP
ajcp-829	53	7	immunocompromised	immunocompromise	VERB
ajcp-829	53	8	children	child	NOUN
ajcp-829	53	9	.	.	PUNCT
ajcp-829	53	10	.	.	PUNCT
ajcp-829	54	1	the	the	DET
ajcp-829	54	2	journal	journal	NOUN
ajcp-829	54	3	of	of	ADP
ajcp-829	54	4	pediatrics	pediatric	NOUN
ajcp-829	54	5	,	,	PUNCT
ajcp-829	54	6	104(1	104(1	NUM
ajcp-829	54	7	)	)	PUNCT
ajcp-829	54	8	,	,	PUNCT
ajcp-829	54	9	134	134	NUM
ajcp-829	54	10	-	-	SYM
ajcp-829	54	11	136	136	NUM
ajcp-829	54	12	.	.	PUNCT
ajcp-829	55	1	https://doi.org/	https://doi.org/	NOUN
ajcp-829	55	2	https://doi.org/10.1016/s0022-3476(84)80611-3	https://doi.org/10.1016/s0022-3476(84)80611-3	NOUN
ajcp-829	55	3	brigden	brigden	VERB
ajcp-829	55	4	,	,	PUNCT
ajcp-829	55	5	d.	d.	PROPN
ajcp-829	55	6	,	,	PUNCT
ajcp-829	55	7	rosling	rosle	VERB
ajcp-829	55	8	,	,	PUNCT
ajcp-829	55	9	a.	a.	PROPN
ajcp-829	55	10	e.	e.	PROPN
ajcp-829	55	11	,	,	PUNCT
ajcp-829	55	12	&	&	CCONJ
ajcp-829	55	13	woods	wood	NOUN
ajcp-829	55	14	,	,	PUNCT
ajcp-829	55	15	n.	n.	PROPN
ajcp-829	55	16	c.	c.	PROPN
ajcp-829	55	17	(	(	PUNCT
ajcp-829	55	18	1982	1982	NUM
ajcp-829	55	19	)	)	PUNCT
ajcp-829	55	20	.	.	PUNCT
ajcp-829	56	1	renal	renal	ADJ
ajcp-829	56	2	function	function	NOUN
ajcp-829	56	3	after	after	ADP
ajcp-829	56	4	acyclovir	acyclovir	PROPN
ajcp-829	56	5	intravenous	intravenous	ADJ
ajcp-829	56	6	injection	injection	NOUN
ajcp-829	56	7	.	.	PUNCT
ajcp-829	57	1	the	the	DET
ajcp-829	57	2	american	american	PROPN
ajcp-829	57	3	journal	journal	PROPN
ajcp-829	57	4	of	of	ADP
ajcp-829	57	5	medicine	medicine	NOUN
ajcp-829	57	6	,	,	PUNCT
ajcp-829	57	7	73(1	73(1	NUM
ajcp-829	57	8	)	)	PUNCT
ajcp-829	57	9	,	,	PUNCT
ajcp-829	57	10	182	182	NUM
ajcp-829	57	11	-	-	SYM
ajcp-829	57	12	185	185	NUM
ajcp-829	57	13	.	.	PUNCT
ajcp-829	58	1	chawla	chawla	PROPN
ajcp-829	58	2	,	,	PUNCT
ajcp-829	58	3	l.	l.	PROPN
ajcp-829	58	4	,	,	PUNCT
ajcp-829	58	5	bellomo	bellomo	PROPN
ajcp-829	58	6	,	,	PUNCT
ajcp-829	58	7	r.	r.	PROPN
ajcp-829	58	8	,	,	PUNCT
ajcp-829	58	9	bihorac	bihorac	PROPN
ajcp-829	58	10	,	,	PUNCT
ajcp-829	58	11	a.	a.	PROPN
ajcp-829	58	12	et	et	PROPN
ajcp-829	58	13	al	al	PROPN
ajcp-829	58	14	.	.	PROPN
ajcp-829	58	15	.	.	PUNCT
ajcp-829	59	1	(	(	PUNCT
ajcp-829	59	2	2017	2017	NUM
ajcp-829	59	3	)	)	PUNCT
ajcp-829	59	4	.	.	PUNCT
ajcp-829	60	1	acute	acute	ADJ
ajcp-829	60	2	kidney	kidney	NOUN
ajcp-829	60	3	disease	disease	NOUN
ajcp-829	60	4	and	and	CCONJ
ajcp-829	60	5	renal	renal	ADJ
ajcp-829	60	6	recovery	recovery	NOUN
ajcp-829	60	7	:	:	PUNCT
ajcp-829	60	8	consensus	consensus	NOUN
ajcp-829	60	9	report	report	NOUN
ajcp-829	60	10	of	of	ADP
ajcp-829	60	11	the	the	DET
ajcp-829	60	12	acute	acute	ADJ
ajcp-829	60	13	disease	disease	NOUN
ajcp-829	60	14	quality	quality	NOUN
ajcp-829	60	15	initiative	initiative	NOUN
ajcp-829	60	16	(	(	PUNCT
ajcp-829	60	17	adqi	adqi	ADV
ajcp-829	60	18	)	)	PUNCT
ajcp-829	61	1	16	16	NUM
ajcp-829	61	2	workgroup	workgroup	NOUN
ajcp-829	61	3	.	.	PUNCT
ajcp-829	62	1	nat	nat	PROPN
ajcp-829	62	2	rev	rev	VERB
ajcp-829	62	3	nephrol	nephrol	PROPN
ajcp-829	62	4	13	13	NUM
ajcp-829	62	5	,	,	PUNCT
ajcp-829	62	6	241	241	NUM
ajcp-829	62	7	-	-	NUM
ajcp-829	62	8	257	257	NUM
ajcp-829	62	9	.	.	PUNCT
ajcp-829	63	1	https://doi	https://doi	PROPN
ajcp-829	63	2	.	.	PUNCT
ajcp-829	63	3	org	org	PROPN
ajcp-829	63	4	/	/	SYM
ajcp-829	63	5	https://doi.org/10.1038	https://doi.org/10.1038	PROPN
ajcp-829	63	6	/	/	SYM
ajcp-829	63	7	nrneph.2017.2	nrneph.2017.2	PROPN
ajcp-829	63	8	.	.	PUNCT
ajcp-829	64	1	gunness	gunness	PROPN
ajcp-829	64	2	p	p	NOUN
ajcp-829	64	3	,	,	PUNCT
ajcp-829	64	4	a.	a.	PROPN
ajcp-829	64	5	k.	k.	PROPN
ajcp-829	64	6	,	,	PUNCT
ajcp-829	64	7	koren	koren	PROPN
ajcp-829	64	8	g.	g.	PROPN
ajcp-829	64	9	(	(	PUNCT
ajcp-829	64	10	2010	2010	NUM
ajcp-829	64	11	)	)	PUNCT
ajcp-829	64	12	.	.	PUNCT
ajcp-829	65	1	the	the	DET
ajcp-829	65	2	effect	effect	NOUN
ajcp-829	65	3	of	of	ADP
ajcp-829	65	4	acyclovir	acyclovir	PROPN
ajcp-829	65	5	on	on	ADP
ajcp-829	65	6	the	the	DET
ajcp-829	65	7	tubular	tubular	ADJ
ajcp-829	65	8	secretion	secretion	NOUN
ajcp-829	65	9	of	of	ADP
ajcp-829	65	10	creatinine	creatinine	NOUN
ajcp-829	65	11	in	in	ADP
ajcp-829	65	12	vitro	vitro	X
ajcp-829	65	13	.	.	PUNCT
ajcp-829	66	1	j	j	PROPN
ajcp-829	66	2	transl	transl	PROPN
ajcp-829	66	3	med	med	PROPN
ajcp-829	66	4	.	.	PROPN
ajcp-829	66	5	,	,	PUNCT
ajcp-829	66	6	30(8	30(8	NUM
ajcp-829	66	7	)	)	PUNCT
ajcp-829	66	8	,	,	PUNCT
ajcp-829	66	9	139	139	NUM
ajcp-829	66	10	.	.	PUNCT
ajcp-829	67	1	https://doi.org/10.1186/1479pa	https://doi.org/10.1186/1479pa	PROPN
ajcp-829	67	2	ge	ge	PROPN
ajcp-829	67	3	8	8	NUM
ajcp-829	67	4	5876	5876	NUM
ajcp-829	67	5	-	-	SYM
ajcp-829	67	6	8	8	NUM
ajcp-829	67	7	-	-	PUNCT
ajcp-829	67	8	139	139	NUM
ajcp-829	67	9	izzedine	izzedine	ADJ
ajcp-829	67	10	,	,	PUNCT
ajcp-829	67	11	h.	h.	PROPN
ajcp-829	67	12	,	,	PUNCT
ajcp-829	67	13	launay	launay	NOUN
ajcp-829	67	14	-	-	PUNCT
ajcp-829	67	15	vacher	vacher	NOUN
ajcp-829	67	16	,	,	PUNCT
ajcp-829	67	17	v.	v.	ADV
ajcp-829	67	18	,	,	PUNCT
ajcp-829	67	19	&	&	CCONJ
ajcp-829	67	20	deray	deray	PROPN
ajcp-829	67	21	,	,	PUNCT
ajcp-829	67	22	g.	g.	PROPN
ajcp-829	67	23	(	(	PUNCT
ajcp-829	67	24	2005	2005	NUM
ajcp-829	67	25	)	)	PUNCT
ajcp-829	67	26	.	.	PUNCT
ajcp-829	68	1	antiviral	antiviral	ADJ
ajcp-829	68	2	drug	drug	NOUN
ajcp-829	68	3	-	-	PUNCT
ajcp-829	68	4	induced	induce	VERB
ajcp-829	68	5	nephrotoxicity	nephrotoxicity	NOUN
ajcp-829	68	6	.	.	PUNCT
ajcp-829	69	1	american	american	PROPN
ajcp-829	69	2	journal	journal	PROPN
ajcp-829	69	3	of	of	ADP
ajcp-829	69	4	kidney	kidney	NOUN
ajcp-829	69	5	diseases	disease	NOUN
ajcp-829	69	6	:	:	PUNCT
ajcp-829	69	7	the	the	DET
ajcp-829	69	8	official	official	ADJ
ajcp-829	69	9	journal	journal	NOUN
ajcp-829	69	10	of	of	ADP
ajcp-829	69	11	the	the	DET
ajcp-829	69	12	national	national	PROPN
ajcp-829	69	13	kidney	kidney	PROPN
ajcp-829	69	14	foundation	foundation	PROPN
ajcp-829	69	15	,	,	PUNCT
ajcp-829	69	16	45(5	45(5	PROPN
ajcp-829	69	17	)	)	PUNCT
ajcp-829	69	18	,	,	PUNCT
ajcp-829	69	19	807	807	NUM
ajcp-829	69	20	-	-	SYM
ajcp-829	69	21	817	817	NUM
ajcp-829	69	22	.	.	PUNCT
ajcp-829	70	1	https://doi.org/	https://doi.org/	PROPN
ajcp-829	70	2	https://doi.org/10.1053/j.ajkd.2005.02.010	https://doi.org/10.1053/j.ajkd.2005.02.010	PROPN
ajcp-829	70	3	mason	mason	PROPN
ajcp-829	70	4	,	,	PUNCT
ajcp-829	70	5	w.	w.	PROPN
ajcp-829	70	6	j.	j.	PROPN
ajcp-829	70	7	,	,	PUNCT
ajcp-829	70	8	&	&	CCONJ
ajcp-829	70	9	nickols	nickols	PROPN
ajcp-829	70	10	,	,	PUNCT
ajcp-829	70	11	h.	h.	PROPN
ajcp-829	70	12	h.	h.	PROPN
ajcp-829	70	13	.	.	PUNCT
ajcp-829	71	1	(	(	PUNCT
ajcp-829	71	2	2008	2008	NUM
ajcp-829	71	3	)	)	PUNCT
ajcp-829	71	4	.	.	PUNCT
ajcp-829	72	1	images	image	NOUN
ajcp-829	72	2	in	in	ADP
ajcp-829	72	3	clinical	clinical	ADJ
ajcp-829	72	4	medicine	medicine	NOUN
ajcp-829	72	5	.	.	PUNCT
ajcp-829	73	1	crystalluria	crystalluria	PROPN
ajcp-829	73	2	from	from	ADP
ajcp-829	73	3	acyclovir	acyclovir	PROPN
ajcp-829	73	4	use	use	PROPN
ajcp-829	73	5	.	.	PUNCT
ajcp-829	74	1	the	the	DET
ajcp-829	74	2	new	new	PROPN
ajcp-829	74	3	england	england	PROPN
ajcp-829	74	4	journal	journal	PROPN
ajcp-829	74	5	of	of	ADP
ajcp-829	74	6	medicine	medicine	NOUN
ajcp-829	74	7	,	,	PUNCT
ajcp-829	74	8	358(13	358(13	NUM
ajcp-829	74	9	)	)	PUNCT
ajcp-829	74	10	.	.	PUNCT
ajcp-829	75	1	https://doi.org/	https://doi.org/	PROPN
ajcp-829	75	2	https://doi.org/10.1056/nejmicm066726	https://doi.org/10.1056/nejmicm066726	PROPN
ajcp-829	75	3	(	(	PUNCT
ajcp-829	75	4	14	14	NUM
ajcp-829	75	5	)	)	PUNCT
ajcp-829	75	6	perazella	perazella	NOUN
ajcp-829	75	7	.	.	PUNCT
ajcp-829	75	8	,	,	PUNCT
ajcp-829	75	9	m.	m.	NOUN
ajcp-829	75	10	a.	a.	PROPN
ajcp-829	75	11	(	(	PUNCT
ajcp-829	75	12	1999	1999	NUM
ajcp-829	75	13	)	)	PUNCT
ajcp-829	75	14	.	.	PUNCT
ajcp-829	76	1	crystal	crystal	NOUN
ajcp-829	76	2	-	-	PUNCT
ajcp-829	76	3	induced	induce	VERB
ajcp-829	76	4	acute	acute	ADJ
ajcp-829	76	5	renal	renal	ADJ
ajcp-829	76	6	failure	failure	NOUN
ajcp-829	76	7	.	.	PUNCT
ajcp-829	77	1	american	american	ADJ
ajcp-829	77	2	journal	journal	PROPN
ajcp-829	77	3	of	of	ADP
ajcp-829	77	4	medicine	medicine	NOUN
ajcp-829	77	5	,	,	PUNCT
ajcp-829	77	6	106(4	106(4	NUM
ajcp-829	77	7	)	)	PUNCT
ajcp-829	77	8	,	,	PUNCT
ajcp-829	77	9	459	459	NUM
ajcp-829	77	10	-	-	SYM
ajcp-829	77	11	465	465	NUM
ajcp-829	77	12	.	.	PUNCT
ajcp-829	78	1	ratan	ratan	PROPN
ajcp-829	78	2	.	.	PUNCT
ajcp-829	78	3	,	,	PUNCT
ajcp-829	79	1	p.	p.	PROPN
ajcp-829	79	2	k.	k.	PROPN
ajcp-829	80	1	s.	s.	PROPN
ajcp-829	80	2	a.	a.	PROPN
ajcp-829	80	3	s.	s.	PROPN
ajcp-829	80	4	k.	k.	PROPN
ajcp-829	80	5	(	(	PUNCT
ajcp-829	80	6	2003	2003	NUM
ajcp-829	80	7	)	)	PUNCT
ajcp-829	80	8	.	.	PUNCT
ajcp-829	81	1	a	a	DET
ajcp-829	81	2	case	case	NOUN
ajcp-829	81	3	of	of	ADP
ajcp-829	81	4	chronic	chronic	ADJ
ajcp-829	81	5	renal	renal	ADJ
ajcp-829	81	6	dysfunction	dysfunction	NOUN
ajcp-829	81	7	following	follow	VERB
ajcp-829	81	8	treatment	treatment	NOUN
ajcp-829	81	9	with	with	ADP
ajcp-829	81	10	oral	oral	ADJ
ajcp-829	81	11	acyclovir	acyclovir	NOUN
ajcp-829	81	12	.	.	PUNCT
ajcp-829	82	1	scandinavian	scandinavian	ADJ
ajcp-829	82	2	journal	journal	PROPN
ajcp-829	82	3	of	of	ADP
ajcp-829	82	4	infectious	infectious	ADJ
ajcp-829	82	5	diseases	disease	NOUN
ajcp-829	82	6	,	,	PUNCT
ajcp-829	82	7	35(10	35(10	NUM
ajcp-829	82	8	)	)	PUNCT
ajcp-829	82	9	,	,	PUNCT
ajcp-829	82	10	770772	770772	NUM
ajcp-829	82	11	.	.	PUNCT
ajcp-829	83	1	sawyer	sawyer	PROPN
ajcp-829	83	2	,	,	PUNCT
ajcp-829	83	3	m.	m.	PROPN
ajcp-829	83	4	h.	h.	PROPN
ajcp-829	83	5	,	,	PUNCT
ajcp-829	83	6	webb	webb	PROPN
ajcp-829	83	7	,	,	PUNCT
ajcp-829	83	8	d.	d.	PROPN
ajcp-829	83	9	e.	e.	PROPN
ajcp-829	83	10	,	,	PUNCT
ajcp-829	83	11	balow	balow	PROPN
ajcp-829	83	12	,	,	PUNCT
ajcp-829	83	13	j.	j.	PROPN
ajcp-829	83	14	e.	e.	PROPN
ajcp-829	83	15	,	,	PUNCT
ajcp-829	83	16	&	&	CCONJ
ajcp-829	83	17	straus	straus	PROPN
ajcp-829	83	18	,	,	PUNCT
ajcp-829	83	19	s.	s.	PROPN
ajcp-829	83	20	e.	e.	PROPN
ajcp-829	83	21	(	(	PUNCT
ajcp-829	83	22	1988	1988	NUM
ajcp-829	83	23	)	)	PUNCT
ajcp-829	83	24	.	.	PUNCT
ajcp-829	84	1	acyclovir	acyclovir	PROPN
ajcp-829	84	2	-	-	PUNCT
ajcp-829	84	3	induced	induce	VERB
ajcp-829	84	4	renal	renal	ADJ
ajcp-829	84	5	failure	failure	NOUN
ajcp-829	84	6	:	:	PUNCT
ajcp-829	84	7	clinical	clinical	ADJ
ajcp-829	84	8	course	course	NOUN
ajcp-829	84	9	and	and	CCONJ
ajcp-829	84	10	histology	histology	NOUN
ajcp-829	84	11	.	.	PUNCT
ajcp-829	85	1	the	the	DET
ajcp-829	85	2	american	american	PROPN
ajcp-829	85	3	journal	journal	PROPN
ajcp-829	85	4	of	of	ADP
ajcp-829	85	5	medicine	medicine	NOUN
ajcp-829	85	6	,	,	PUNCT
ajcp-829	85	7	84(6	84(6	NOUN
ajcp-829	85	8	)	)	PUNCT
ajcp-829	85	9	,	,	PUNCT
ajcp-829	85	10	1067	1067	NUM
ajcp-829	85	11	-	-	SYM
ajcp-829	85	12	1071	1071	NUM
ajcp-829	85	13	.	.	PUNCT
ajcp-829	86	1	wade	wade	PROPN
ajcp-829	86	2	jc	jc	PROPN
ajcp-829	86	3	,	,	PUNCT
ajcp-829	86	4	m.	m.	PROPN
ajcp-829	86	5	j.	j.	PROPN
ajcp-829	86	6	(	(	PUNCT
ajcp-829	86	7	1983	1983	NUM
ajcp-829	86	8	)	)	PUNCT
ajcp-829	86	9	.	.	PUNCT
ajcp-829	87	1	neurologic	neurologic	ADJ
ajcp-829	87	2	symptoms	symptom	NOUN
ajcp-829	87	3	associated	associate	VERB
ajcp-829	87	4	with	with	ADP
ajcp-829	87	5	parenteral	parenteral	ADJ
ajcp-829	87	6	acyclovir	acyclovir	PROPN
ajcp-829	87	7	treatment	treatment	NOUN
ajcp-829	87	8	after	after	ADP
ajcp-829	87	9	marrow	marrow	NOUN
ajcp-829	87	10	transplantation	transplantation	NOUN
ajcp-829	87	11	.	.	PUNCT
ajcp-829	88	1	ann	ann	PROPN
ajcp-829	88	2	intern	intern	PROPN
ajcp-829	88	3	med	me	VERB
ajcp-829	88	4	,	,	PUNCT
ajcp-829	88	5	98	98	NUM
ajcp-829	88	6	,	,	PUNCT
ajcp-829	88	7	921	921	NUM
ajcp-829	88	8	-	-	SYM
ajcp-829	88	9	925	925	NUM
ajcp-829	88	10	.	.	PUNCT
ajcp-829	89	1	yildiz	yildiz	PROPN
ajcp-829	89	2	c	c	PROPN
ajcp-829	89	3	,	,	PUNCT
ajcp-829	89	4	o.	o.	PROPN
ajcp-829	89	5	y.	y.	PROPN
ajcp-829	89	6	,	,	PUNCT
ajcp-829	89	7	gucer	gucer	NOUN
ajcp-829	89	8	s	s	PROPN
ajcp-829	89	9	,	,	PUNCT
ajcp-829	89	10	cengiz	cengiz	PROPN
ajcp-829	89	11	ab	ab	PROPN
ajcp-829	89	12	,	,	PUNCT
ajcp-829	89	13	topaloglu	topaloglu	PROPN
ajcp-829	89	14	r.	r.	PROPN
ajcp-829	89	15	(	(	PUNCT
ajcp-829	89	16	2013	2013	NUM
ajcp-829	89	17	)	)	PUNCT
ajcp-829	89	18	.	.	PUNCT
ajcp-829	90	1	acute	acute	PROPN
ajcp-829	90	2	kidney	kidney	PROPN
ajcp-829	90	3	injury	injury	NOUN
ajcp-829	90	4	due	due	ADP
ajcp-829	90	5	to	to	ADP
ajcp-829	90	6	acyclovir	acyclovir	PROPN
ajcp-829	90	7	.	.	PUNCT
ajcp-829	91	1	cen	cen	PROPN
ajcp-829	91	2	case	case	PROPN
ajcp-829	91	3	rep	rep	PROPN
ajcp-829	91	4	,	,	PUNCT
ajcp-829	91	5	1	1	NUM
ajcp-829	91	6	,	,	PUNCT
ajcp-829	91	7	38	38	NUM
ajcp-829	91	8	-	-	SYM
ajcp-829	91	9	40	40	NUM
ajcp-829	91	10	.	.	PUNCT
ajcp-829	92	1	https://doi.org/10.1007/s13730-012-0035-0	https://doi.org/10.1007/s13730-012-0035-0	NUM
ajcp-829	93	1	yy	yy	INTJ
ajcp-829	93	2	.	.	PROPN
ajcp-829	93	3	,	,	PUNCT
ajcp-829	93	4	b.	b.	PROPN
ajcp-829	93	5	(	(	PUNCT
ajcp-829	93	6	1984	1984	NUM
ajcp-829	93	7	)	)	PUNCT
ajcp-829	93	8	.	.	PUNCT
ajcp-829	94	1	the	the	DET
ajcp-829	94	2	use	use	NOUN
ajcp-829	94	3	of	of	ADP
ajcp-829	94	4	acyclovir	acyclovir	PROPN
ajcp-829	94	5	in	in	ADP
ajcp-829	94	6	children	child	NOUN
ajcp-829	94	7	.	.	PUNCT
ajcp-829	95	1	pediatric	pediatric	ADJ
ajcp-829	95	2	infectious	infectious	ADJ
ajcp-829	95	3	disease	disease	NOUN
ajcp-829	95	4	,	,	PUNCT
ajcp-829	95	5	3(4	3(4	NUM
ajcp-829	95	6	)	)	PUNCT
ajcp-829	95	7	,	,	PUNCT
ajcp-829	95	8	575	575	NUM
ajcp-829	95	9	-	-	SYM
ajcp-829	95	10	578	578	NUM
ajcp-829	95	11	.	.	PUNCT
ajcp-829	96	1	https://doi.org/	https://doi.org/	VERB
ajcp-829	96	2	https://doi.org/10.1097/00006454-19840700000017	https://doi.org/10.1097/00006454-19840700000017	PROPN
ajcp-829	96	3	zhang	zhang	PROPN
ajcp-829	96	4	y	y	PROPN
ajcp-829	96	5	,	,	PUNCT
ajcp-829	96	6	c.	c.	PROPN
ajcp-829	96	7	y.	y.	PROPN
ajcp-829	96	8	,	,	PUNCT
ajcp-829	96	9	teng	teng	PROPN
ajcp-829	96	10	y.	y.	PROPN
ajcp-829	96	11	(	(	PUNCT
ajcp-829	96	12	2016	2016	NUM
ajcp-829	96	13	)	)	PUNCT
ajcp-829	96	14	.	.	PUNCT
ajcp-829	97	1	acute	acute	PROPN
ajcp-829	97	2	renal	renal	ADJ
ajcp-829	97	3	injury	injury	NOUN
ajcp-829	97	4	induced	induce	VERB
ajcp-829	97	5	by	by	ADP
ajcp-829	97	6	valacyclovir	valacyclovir	NOUN
ajcp-829	97	7	hydrochloride	hydrochloride	NOUN
ajcp-829	97	8	:	:	PUNCT
ajcp-829	97	9	a	a	DET
ajcp-829	97	10	case	case	NOUN
ajcp-829	97	11	report	report	NOUN
ajcp-829	97	12	.	.	PUNCT
ajcp-829	98	1	exp	exp	NOUN
ajcp-829	98	2	ther	ther	PROPN
ajcp-829	98	3	med	me	VERB
ajcp-829	98	4	,	,	PUNCT
ajcp-829	98	5	6	6	NUM
ajcp-829	98	6	,	,	PUNCT
ajcp-829	98	7	4025	4025	NUM
ajcp-829	98	8	-	-	SYM
ajcp-829	98	9	4028	4028	NUM
ajcp-829	98	10	.	.	PUNCT
ajcp-829	99	1	https://doi.org/10.3892/	https://doi.org/10.3892/	PROPN
ajcp-829	99	2	etm.2016.3905	etm.2016.3905	NUM
ajcp-829	99	3	.	.	PUNCT